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Heart rate (HR) is one of most easily measured exercise test variables. Although easily 
measured, the HR reflects a complex, integrated physiologic response: autonomic tone, 
central and peripheral reflexes, hormonal influences, and factors intrinsic to the heart are 
all important. During the last two decades the exercise test derived HR variables have 
excited widely as prognostic markers of mortality and cardiac events both in asymptomatic 
persons as well as in cardiovascular disease (CVD) patients.  
Workload achieved at HR of 100 beats/min (WL100) was assessed using a maximal, 
symptom-limited exercise test on an electrically braked cycle ergometer. The complete 
data on exercise test variables was available for 1679 men in a population based sample of 
men. During the follow-up of eleven years, the deaths were ascertained by linkage to the 
National Death Registry. 
One SD decrement in WL100 was related to an increased risk of CVD death (RR 1.7, 95% 
CI 1.3-2.4) and all-cause death (RR 1.7, 95% CI 1.3-2.2) in men without CHD at baseline 
and in men with known or suspected CHD at baseline after adjusting for risk factors, 
respectively. The exclusion of men who had an outcome event during the first two years of 
follow-up did not affect the results. A low WL100 was associated with a high resting HR 
and a low maximal oxygen uptake but in survival analyses a low WL100 still provided 
additional prognostic information beyond these variables. 
A low workload achieved at a submaximal HR of 100 beats/min predicts CVD and CHD 
mortality in men without CHD as well as all-cause death in men with known or suspected 
CHD. Contrary to previous interpretations, an exaggerated HR response at a low workload 
seems to indicate an increased risk by itself instead of being only a surrogate marker of a 
low cardiorespiratory fitness. In the current study sample several exercise test variables 
predict outcomes independent of each other and conventional risk factors. This emphasizes 
the importance of measuring several variables at submaximal and maximal workload as 
well as during recovery phase in order to maximize the prognostic yield obtained from the 
exercise test. 
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1 INTRODUCTION 
 
Coronary heart disease (CHD) is the leading cause of death in the developed world 
(Pasternak et al. 2003) and may become the leading cause of death in the entire world 
(Murray and Lopez 1997). Although the incidence of CHD has been decreasing over the 
last two decades, the prevalence is expected to increase given the increasing elderly 
population (Shetler et al. 2001, Froelicher et al. 2002, Froelicher et al. 2003). It is 
important to implement cost-effective strategies that direct the appropriate individuals to 
the optimal risk reduction procedures through risk prediction (Ashley et al. 2002, 
Froelicher et al. 2002, Froelicher et al. 2003). There is a growing awareness of the need to 
apply statistical techniques to develop evidence-based scores for better decision-making 
(Swets et al. 2000). The goal of risk prediction through statistical methods is to provide a 
logical estimate as to the likelihood of the occurrence of important deleterious clinical 
events (Shetler et al. 2001, Froelicher et al. 2002, Froelicher et al. 2003). The most 
important outcome is death but the future risk of nonfatal clinical outcomes is an important 
element of risk evaluation as well (Shetler et al. 2001, Froelicher et al. 2002, Froelicher et 
al. 2003). Based on the worldwide epidemiological experience, the evaluation of 
cardiovascular risk is based on four time-honoured classical cardiovascular disease (CVD) 
risk factors: age, serum cholesterol, resting systolic blood pressure and smoking status (De 
Backer et al. 2003).  
 
Exercise testing is not recommended in asymptomatic subjects due to both lacking 
evidence of its value and because false positive exercise electrocardiograms (ECGs) are 
common (Erikssen et al. 2004). However, the real issue is not to identify CHD but to 
predict outcome (Gibbons et al. 2002a). Because of this, increasing attention has been 
focused on the exercise test as a prognostic, as opposed to diagnostic, modality (Ashley et 
al. 2000a; Lauer 2001b). It is well known that several exercise test indices, besides ECG 
findings, such as exercise capacity (Erikssen et al. 2004, Laukkanen et al. 2007), heart rate 
(HR) (Ekelund et al. 1988, Slattery and Jacobs 1988) and blood pressure (BP) responses 
(Mundal et al. 1994) to exercise, are strong predictors of CVD events.  
 
Exercise is the body’s most common physiologic stress, and it places major demands on 
the cardiovascular system (Froelicher and Myers 2006). Exercise test provides a precise 
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and powerful noninvasive tool that permits the study of the regulation of the cardiovascular 
system under rigorously controlled and highly reproducible conditions, which include the 
full range of its functional capacity (Rowell 1993). The adaptations that occur during an 
exercise test allow the body to increase its resting metabolic rate up to 20 times, during 
which time cardiac output may increase as much as six times (Navare and Thompson 2003, 
Froelicher and Myers 2006). The obvious advantage to the researcher is that more is 
learned about how a system operates when it is forced to perform than when it is idle 
(Rowell 1993). Acute exercise can elicit cardiovascular abnormalities that are not present 
at rest, and it can be used to determine the adequacy of cardiovascular function (Navare 
and Thompson 2003). 
 
Heart rate is one of most easily measured exercise test variables. Although easily 
measured, the HR reflects a complex, integrated physiologic response: autonomic tone, 
central and peripheral reflexes, hormonal influences, and factors intrinsic to the heart are 
all important (Hammond and Froelicher 1985, Hainsworth 1995, Iellamo 2001). Recently, 
the changes in HR during and after exercise have emerged as powerful measures of risk for 
future CVD event in their own right (Lauer 2001c). An interesting fact from viewpoint of 
basic exercise physiology is that the mechanisms mediating the association of exercise HR 
variables and an increased risk of outcomes are largely unknown (Ellestad 1996, Chaitman 
2003, Routledge and Townend 2006).  
 
Office-based assessment of conventional risk factor burden is necessary but may not 
accurately estimate risk of future CVD events (Brindle et al. 2006). There is a need for 
easily available non-invasive methods to detect individuals with an increased risk of CVD 
events who would probably benefit most from preventive measures (Laukkanen 2005). The 
main aim of the current study is identify variables derived from exercise test HR which 
might serve as useful predictors for future CVD events and possibly provide additional 
prognostic information to conventional risk factors in a population based sample of 
middle-aged men.  
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2 REVIEW OF LITERATURE 
 
2.1 SINOATRIAL NODE  
 
The normal heart beat starts in the sinoatrial (SA) node (Hammond and Froelicher 1985, 
Hainsworth 1995, Camm and Fei 1996a). The normal HR is determined by the firing 
frequency of SA node (Hammond and Froelicher 1985, Hainsworth 1995, Camm and Fei 
1996a). The SA node is a small, flattened, ellipsoid strip of specialized cardiac muscle and 
associated fibroelastic connective tissue about 3 mm wide, 15 mm long, and 1 mm thick 
(Hariman et al. 1980, Camm and Fei 1996a, Awtry and Loscalzo 2001b). It contains 
clusters of cells, poor in contractile filaments, where the automatic activity resides mostly 
in the pacemaker or P cells (Opie 1991). In contrast are transitional cells, which lie near the 
periphery of the SA node (Brown 1982). The SA node is located in the superior lateral wall 
of the right atrium immediately below and slightly lateral to the opening of the superior 
vena cava, near the superior end of the sulcus terminalis (Hammond and Froelicher 1985, 
Bouman and Jongsma 1986, Camm and Fei 1996a). Its primary source of blood is from SA 
nodal artery which originates from the right coronary artery in about 60% of humans 
(Camm and Fei 1996a, Moore and Dalley 1999, Mangrum and DiMarco 2000). 
 
The normal cardiac impulses starts at the SA node, passes through the atrial tissue through 
preferential internodal tracts to the atrioventricular (AV) node where it slows, and then 
continues down the His-Purkinje system to the ventricular myocardium, where the wave of 
depolarization terminates because there is no further tissue to depolarize (Hammond and 
Froelicher 1985, Awtry and Loscalzo 2001b, Moore 2006). Further conduction occurs only 
after a new impulse is formed in the SA node (Awtry and Loscalzo 2001a). 
 
Many cardiac cells, especially the cells of the heart’s specialized conducting system, have 
the capability of self excitation, a process that can cause automatic rhythmical discharge 
and conduction (Guyton and Hall 1996). The resting potential of a typical cardiac cell is -
80 to -90 millivolts (mV) (Guyton and Hall 1996, Awtry and Loscalzo 2001a). When it is 
depolarized to a certain threshold level (threshold potential), an action potential is 
produced as a result of a complex series of ionic shifts (Guyton and Hall 1996, Awtry and 
Loscalzo 2001a, Moore 2006). The appearance of the action potential of SA nodal cells is 
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different from that of the typical myocyte (Guyton and Hall 1996, Awtry and Loscalzo 
2001a). The normal resting potential of these cells is higher (-55 to -60 mV), and the 
spontaneous diastolic depolarization is much more pronounced (Binah and Rosen 1992, 
Guyton and Hall 1996, Awtry and Loscalzo 2001a). The slope of the diastolic 
depolarization determines the rate at which a cell will spontaneously depolarize 
(automaticy) until it reaches threshold potential, thus generating an action potential that is 
then propagated to surrounding cells (Braunwald and Ross 1979, Guyton and Hall 1996, 
Awtry and Loscalzo 2001a).  
 
The spontaneous cyclic depolarization of primary pacemaker cells in the SA node that 
establish intrinsic HR arises from the unique time-dependent characteristics of a variety of 
depolarizing and hyperpolarizing currents (Irisawa et al. 1993, Guyton and Hall 1996, 
Moore 2006). The ionic basis of SA node pacemaker activity is that action potential 
configuration is determined mainly by outward hyperpolarizing K+ current, IK, and two 
depolarizing inward currents, ICa and If, that are carried primarily by Ca2+ and Na+, 
respectively (Podrid et al. 1990, Binah and Rosen 1992, Moore 2006). At the termination 
of one SA node action potential, the membrane voltage does not stabilize to a negative 
level but slowly creeps up with an approximately constant slope, until it reaches the 
threshold for a new SA node action potential (DiFrancesco 1993, Guyton and Hall 1996). 
The gradual membrane depolarization has been attributed to an overall diminution in the 
net conductance of hyperpolarizing K+ currents and a constant background inward current 
caused by the spontaneous inward movement along the concentration gradient for Na+ ions 
(Maylie and Morad 1984, Baruscotti et al. 2005, Moore 2006). A major role, however, in 
the generation and control of the diastolic depolarization is played by a prominent increase 
in an inward depolarizing current If (Guyton and Hall 1996, Baruscotti et al. 2005, Moore 
2006). An initial membrane depolarization leads to the activation of a transient (T-type) 
Ca2+ current (ICa,T) which results in Ca2+ influx into a confined subsarcolemmal space 
between the sarcolemma and sarcoplasmic reticulum, and [Ca2+] in the subsarcolemmal 
space begins to increase (Irisawa et al. 1993, Moore 2006). This triggers the focal release 
of Ca2+ (sparks) from sarcoplasmic reticulum Ca2+ release channels, further increasing 
[Ca2+] in the space (Moore 2006). This in turn leads to the activation of forward Na+-Ca2+ 
exchange (INCX) and further membrane depolarization toward a threshold potential (Moore 
2006). Since the stoichiometry of the exchange is three Na+ for one Ca2+, the current is 
electrogenic and mediates a net inward current, INaCa (Irisawa et al. 1993, Moore 2006). 
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The interrelated actions of ICa,T, sarcoplasmic reticulum Ca2+ sparks, and INaCa creates a 
positive feedback loop that culminates in a progressive membrane depolarization to a 
threshold potential (Moore 2006). Once threshold is achieved, an L-type inward Ca2+ 
current (ICa) rapidly activates, and an action potential is triggered (Podrid et al. 1990, 
Irisawa et al. 1993, DiFrancesco 1995). 
 
The SA node usually has the fastest diastolic depolarization and thus functions as the 
normal pacemaker of the heart (Hammond and Froelicher 1985, Hainsworth 1995, Camm 
and Fei 1996a). If the SA node fails, the AV node has the next fastest pacemaker rate 
(approximately 40-60 beats/min) (Hainsworth 1995, Guyton and Hall 1996, Awtry and 
Loscalzo 2001a). 
 
2.2 CARDIAC INNERVATION 
 
The normal myocardium is richly innervated by the autonomic nervous system (Levy and 
Martin 1979, Awtry and Loscalzo 2001b). The heart is supplied by autonomic nerve fibers 
from superficial and deep cardiac plexuses from which three major cardiac nerves project 
into the heart (Janes et al. 1986, Moore and Dalley 1999). These nerve networks lie 
between the bifurcation of the trachea and the ascending aorta, and superior to the 
bifurcation of the pulmonary artery (Moore and Dalley 1999). The parasympathetic supply 
is from preganglionic cardiac branches of the vagus nerves (Shields 1993, Hainsworth 
1995, Freeman et al. 2006,). The cell bodies of the parasympathetic postganglionic fibers 
constitute intrinsic ganglia in the vicinity of SA and AV nodes (Levy and Martin 1979, 
Hammond and Froelicher 1985, Shields 1993). The postganglionic parasympathetic fibers 
innervates the atria but has few projections to the ventricles although there is increasing 
evidence to show that the vagal nerves innervate the ventricular myocardium as well (Levy 
and Martin 1979, Standish et al. 1994, Johnson et al. 2004). The cell bodies of cardiac 
afferent vagal neurons are contained within the nodose ganglia inferior to the jugular 
foramen (Shields 1993, Moore and Dalley 1999, Browning and Mendelowitz 2003). The 
central fibers of these bipolar neurons continue to ascend in the vagus to enter the brain 
stem (Shields 1993, Moore and Dalley 1999, Browning and Mendelowitz 2003). 
 
Both pre- and postganglionic cardiac parasympathetic fibers release acetylcholine as 
neurotransmitter (Levy and Martin 1979, Shields 1993, Freeman et al. 2006). The effects 
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of acetylcholine on the heart are mediated by muscarinic M2-receptors but the neural 
transmission between pre- and postganglionic fibers of both the sympathetic and 
parasympathetic systems is mediated by nicotinic NN-receptors (Shields 1993, Moore and 
Dalley 1999, Freeman et al. 2006). Once the acetylcholine has been secreted, it persists in 
the tissue for a few seconds; then most of it is split into an acetate ion and choline by the 
enzyme acetylcholinesterase (Levy and Martin 1979, Berne and Levy 1988).  
 
The sympathetic supply is from postganglionic cardiac sympathetic fibers (Hammond and 
Froelicher 1985, Hainsworth 1995, Freeman et al. 2006). The cell bodies of pre- and 
postganglionic fibers are in the intermediolateral cell columns of the lateral horns of the 
superior five or six thoracic segments of the spinal cord, and in the cervical and superior 
thoracic paravertebral ganglia of the sympathetic trunks, respectively (Hammond and 
Froelicher 1985, Hainsworth 1995, Freeman et al. 2006). Sympathetic nerve terminals are 
located throughout the atria and ventricles (Hammond and Froelicher 1985, Shepherd 
1987, Hainsworth 1995). The cardiac afferent sympathetic neurons have their cell bodies in 
C6-T6 dorsal root ganglia, and they enter the dorsal horn of the spinal cord (Shields 1993, 
Moore and Dalley 1999, Bear et al. 2001). They synapse on cells in the outer part of the 
dorsal horn, the axons of the second-order neurons immediately decussate and ascend 
through the spinothalamic tract to reach the thalamus (Shields 1993, Bear et al. 2001).    
 
Pre- and postganglionic cardiac sympathetic fibers release acetylcholine and noradrenaline 
as neurotransmitters, respectively (Hammond and Froelicher 1985, Shields 1993, Freeman 
et al. 2006). In addition to sympathetic innervation directly from sympathetic nerve 
endings, sympathetic nervous system may have an effect indirectly by stimulating adrenal 
medulla to secrete adrenaline and noradrenaline into the circulating blood and these two 
hormones can further bind to the adrenergic receptors of the heart (Shields 1993, Guyton 
and Hall 1996, Freeman et al. 2006,). The effects of noradrenaline and adrenaline on the 
heart are mediated by α1-, β1- and β2-adrenergic receptors of which β1 is the most abundant 
subtype in the heart representing approximately 75% of total (Hammond and Froelicher 
1985, Bristow et al. 1990, Freeman et al. 2006). Noradrenaline excites mainly α-receptors 
but excites the β-receptors to a less extent as well whereas adrenaline excites both types of 
receptors approximately eqally (Parkinson 1990, Guyton and Hall 1996). Noradrenaline is 
removed from the secretory site in three ways: (i) reuptake into the adrenergic nerve 
ending (accounting for removal of 50%-80% of the secreted noradrenaline); (ii) diffusion 
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away into the surrounding body fluids; and (iii) destruction by enzymes (Levy and Martin 
1979, Berne and Levy 1988, Opie 1991).  
 
The latency of the response of the SA node to vagal stimulation is very short (Levy and 
Martin 1979, Rowell 1993, Hainsworth 1995). After a single stimulus, the maximum 
response has been reported to occur within only 400 milliseconds (Levy et al. 1970, Levy 
and Martin 1979, Rowell 1993). Thus, vagal stimulation results in a peak response either in 
the first or in the second beat after its onset (Levy and Martin 1979, Hainsworth 1995). On 
the other hand, following the onset of sympathetic stimulation, there is a latent period of up 
to 5 seconds followed by a progressive increase in HR which reaches a steady level in 20 
to 30 seconds (Levy and Martin 1979, Rowell 1993, Hainsworth 1995). Both 
parasympathetic and sympathetic preganglionic fibers are myelinated whereas 
postganglionic fibers do not have myelin sheath (Barron and Chokroverty 1993, Shields 
1993). The fact that parasympathetic postganglionic fibers are clearly shorter than 
sympathetic postganglionic fibers partly explains the slower cardiac responses to 
sympathetic stimuli compared to parasympathetic ones because the neural transmission is 
faster in myelinated fibers (Guyton and Hall 1996). 
 
HR is determined from ECG as the reciprocal of the time interval between two successive 
R peaks (which reflect depolarization of ventricles) and expressed as beats/minute 
(Hammond and Froelicher 1985, Froelicher and Myers 2006). The intrinsic HR, in absence 
of any neurohumoral influence, is about 100 to 120 beats/min and declines with age (Jose 
and Taylor 1969, Lewis et al. 1980, Hainsworth 1995). Without neurohumoral influence 
maximal HR at peak exercise is 18-24% lower than with intact neurohumoral influence 
(Ekblom et al. 1972, Lewis et al. 1980). In the intact, unblocked individual, the HR at any 
time represents the net effect of the vagal (parasympathetic) and the sympathetic nerves 
which play a key role in the regulation of the HR by modulating the intrinsic pacemaker 
activity of the heart (Ekblom et al. 1973, Mangrum and DiMarco 2000, Navare and 
Thompson 2003). In resting conditions, both autonomic divisions are thought to be 
tonically active with the vagal effects dominant (Hammond and Froelicher 1985, Mangrum 
and DiMarco 2000, Freeman et al. 2006). In normal adults at rest, the HR is about 70 to 85 
beats/min and the normal range is 60 to 100 beats/min (Ekblom et al. 1973, Spodick et al. 
1992, Camm and Fei 1996a). 
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SA and AV nodes are the most densely innervated regions of the heart and are most 
affected by changes in autonomic tone, allowing for neural regulation of the HR (Levy and 
Martin 1979, Moore 2006). There is some asymmetry in the distribution of autonomic 
fibers to the heart, and the SA node is predominantly innervated by fibers from the right 
side (Stone and Liang 1984, Hainsworth 1995, Camm and Fei 1996a). Weak to moderate 
vagal stimulation will slow the HR often to as little as one-half normal (Levy and Martin 
1979, Guyton and Hall 1996). Strong vagal stimulation of the heart can stop the heartbeat 
for a few seconds but then the heart usually “escapes” and beats at a rate of 20 to 40 
beats/min thereafter paced by a pacemaker elsewhere than SA node (Hainsworth 1995, 
Guyton and Hall 1996, Mangrum and DiMarco 2000). Increased vagal input into the SA 
node results in the release of acetylcholine from nerve endings at the SA node and released 
acetylcholine binds to muscarinic receptors (Levy and Martin 1979, Guyton and Hall 1996, 
Moore 2006). Acetylcholine can directly activate a specific class of K+ channels (KACh) in 
SA node cells which produces a hyperpolarizing current that opposes the effects of 
depolarizing currents during diastole (Levy and Martin 1979, Irisawa et al. 1993, Moore 
2006). Second, the release of acetylcholine slows HR by suppressing membrane-bound 
adenylate cyclase activity via a G-protein-coupled M2-adenylate cyclase mechanism (see 
next paragraph) (Irisawa et al. 1993, DiFrancesco 1995, Baruscotti et al. 2005). The former 
mechanism is more prominent at higher levels of vagal activation and explains 
acetylcholine-mediated action potential hyperpolarization (Irisawa et al. 1993, Moore 
2006). The latter mechanism occurs at lower levels of vagal activation and provides a 
conceptual explanation for a reduction in the rate of diastolic depolarization without 
prominent membrane hyperpolarization (Irisawa et al. 1993, Moore 2006). Besides these 
mechanisms vagal activation may affect diastolic depolarization by inducing an upward 
shift in action potential threshold (Moore 2006). The net effect of these three mechanisms 
is to prolong the time required for diastolic depolarization to proceed to an action potential 
threshold (Moore 2006).  
 
An increase in sympathetic activity forms the principal method of increasing HR above the 
intrinsic level generated by the SA node to the maximal levels achieved (Blomqvist and 
Saltin 1983, Hainsworth 1995, Åstrand et al. 2003). Strong sympathetic stimulation can 
increase the HR in adult humans to 180 to 200 beats/min (Guyton and Hall 1996, Wilmore 
and Costill 2004). Sympathetic stimulation, either directly from sympathetic nerve endings 
in the heart (noradrenaline) or indirectly by means of circulating adrenaline, accelerates 
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pacemaker activity of SA node cells (Shepherd 1987, DiFrancesco 1995, Baruscotti et al. 
2005). This manifests itself in a marked increase in the rate of diastolic depolarization and 
an increase in the amplitude of the pacemaker action potential (Podrid et al. 1990, Moore 
2006). The increase in the rate of diastolic depolarization results from cyclic adenosine 
monophosphate-mediated enhanced intracellular Ca2+ handling and from increase in the 
magnitude of If (Irisawa et al. 1993, DiFrancesco 1995, Baruscotti et al. 2005). The 
binding of sympathetic neurotransmitter to β-adrenergic receptor leads to the G-protein-
mediated activation of a membrane-bound adenylate cyclase, the formation of cyclic 
adenosine monophosphate, and subsequent activation of a cyclic adenosine 
monophosphate-dependent protein kinase A (Irisawa et al. 1993, DiFrancesco 1995, 
Baruscotti et al. 2005). The active catalytic subunits of protein kinase A phosphorylates 
sarcoplasmic reticulum Ca2+ pumps and sarcoplasmic reticulum Ca2+ release channels 
leading to enhanced sarcoplasmic reticulum Ca2+ loading as well as increased  Ca2+ sparks 
frequency (Moore 2006). These events culminate in a faster increase in [Ca2+] in the 
subsarcolemmal space and a more robust activation of a depolarizing INCX (Moore 2006). 
On the other hand, the channels mediating If are activated by cyclic adenosine 
monophosphate through the direct binding, and not by protein kinase A-mediated 
phosphorylation (DiFrancesco 1995, Baruscotti et al. 2005). The net effect of these cyclic 
adenosine monophosphate-mediated processes is a shortening of diastolic depolarization 
and an increase in HR (Irisawa et al. 1993, DiFrancesco 1995, Baruscotti et al. 2005). Still 
one possible β-adrenergic-mediated mechanism involves stimulation of Na+-K+-pump 
activity (Opie 1991). The consequent hyperpolarization changes the pacemaker potential in 
early diastole into the zone required for activity of the If current, so that less time is 
required to activate this current to initiate the following diastolic depolarization (Opie 
1991). 
 
2.3 THE REGULATION OF HEART RATE BY CENTRAL NERVOUS SYSTEM 
 
All levels of the central nervous system contribute to the regulation of cardiovascular 
activities, but the main cardiovascular regulating centers are located in the brain stem 
(Levy and Martin 1979, Hammond and Froelicher 1985, Camm and Fei 1996a). Located 
bilaterally mainly in the reticular substance of the medulla and lower third of the pons is an 
area called the vasomotor center (Guyton and Hall 1996, Moore and Dalley 1999). The 
center transmits parasympathetic impulses through the vagus nerves to the heart and 
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transmits sympathetic impulses through the spinal cord and peripheral sympathetic nerves 
to the heart as well as to blood vessels of the body (Levy and Martin 1979, Guyton and 
Hall 1996). From the cardiovascular control viewpoint the most important parts of the 
vasomotor center are the nucleus tractus solitarius, the ventrolateral medulla, the dorsal 
motor nucleus, and the nucleus ambiguus (Seller 1991). The nucleus tractus solitarius, 
which lies in the posterolateral portions of the medulla and lower pons, receives sensory 
nerve signals from thoracic and abdominal organs mostly via vagus nerves as well as from 
carotid sinuses via glossopharyngeal nerves (Shepherd 1987, Potts 2006, Chaitman 2007). 
The output signals from the nucleus tractus solitarius controls the activities of those areas 
in the vasomotor centre which in turn regulate the descending parasympathetic and 
sympathetic output (Spyer 1990, Potts 2006, Chaitman 2007). Widespread areas of the 
higher nervous centers can either excite or inhibit the vasomotor center (Stone and Liang 
1984, Shepherd 1987, Mifflin et al. 1988). The more lateral and superior portions of the 
reticular substance cause excitation, whereas the more medial and inferior portions cause 
inhibition (Guyton and Hall 1996). The hypothalamus can exert either powerful excitatory 
or inhibitory effects on the vasomotor centre: the posterolateral portions cause mainly 
excitation, whereas the anterior part can cause mild excitation or inhibition, depending on 
the precise part of the anterior hypothalamus stimulated (Mifflin et al. 1988, Loewy 1990, 
Guyton and Hall 1996). Of various parts of the cerebral cortex, anterior temporal lobe, the 
orbital areas of the frontal cortex, the anterior part of the cingulate gyrus, the amygdala, the 
septum, and the hippocampus can all either excite or inhibit the vasomotor center, 
depending on the precise portion of these areas that is stimulated and on the intensity of the 
stimulus (Loewy 1990, Guyton and Hall 1996). 
 
The parasympathetic efferent preganglionic neurons are located for the most part in the 
nucleus ambiguus of the medulla, lesser numbers are located in the dorsal motor nucleus 
and the regions in between these two medullary nuclei (Hammond and Froelicher 1985, 
Plecha et al. 1988, Armour 1999). Parasympathetic activity to the SA node originates from 
the central nervous system rather than from peripheral ganglia (Loewy 1990) and section 
of the preganglionic fibers, leaving only postganglionic innervation intact, releases the 
heart from parasympathetic inhibition (Mendelowitz 1999). Preganglionic cardiac vagal 
fibers are tonically active, with a firing pattern that is pulse synchronous and most active 
during postinspiration and reduced during inspiration (a respiratory sinus arrhythmia) 
(Seller 1991, Mendelowitz 1999). The cardiac vagal neurons in the nucleus ambiguus, 
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however, do not display any pacemaker-like activity such as repetitive or phasic 
depolarizations or action potentials but in the absence from synaptic activity those neurons 
are normally silent (Seller 1991, Mendelowitz 1999). The synaptic input to cardiac vagal 
neurons are therefore important in maintaining normal heart rate and cardiac function 
(Mendelowitz 1999). A major pathway to the nucleus ambiguus originates from the 
nucleus tractus solitarius, and electrophysiological experiments demonstrate that the 
pathway is glutamergic (Andresen and Kunze 1994, Standish et al. 1994, Neff et al. 1998). 
It is still unknown whether the nucleus tractus solitarius neurons receiving sensory 
information project directly to cardiac vagal neurons, or whether there are synapses within 
the nucleus tractus solitarius before the sensory information is ultimately communicated to 
cardiac vagal neurons (Seller 1991, Mendelowitz 1999). Cardiac vagal neurons have also 
excitatory input from cholinergic nicotinic neurons which are possibly involved in the 
respiratory sinus arrhythmia (Mendelowitz 1999) and from dopaminergic neurons which 
induce bradycardia via activation of D2-receptors (Chitravanshi and Calaresu 1992).  
 
The ventrolateral medulla consists of rostral (rVLM) and caudal (cVLM) parts and 
population of rVLM neurons (premotor neurons) with their spinal projection to 
interomediolateral cell column constitutes the main and final integration center in the 
brainstem for generating the sympathetic outflow to cardiovascular effector organs (Reis et 
al. 1988, Seller 1991, Potts 2006). Under normal conditions rVLM transmits signals 
continuously to the sympathetic preganglionic fibers in interomediolateral cell column via 
glutamergic transmission (Reis et al. 1988, Seller 1991, Guyton and Hall 1996). This tonic 
sympatho-excitatory activity of rVLM is, however, continuously inhibited by gamma-
aminobutyric acid-mediated transmission from cVML (Reis et al. 1988, Seller 1991, Potts 
2006). cVML in turn receives tonic glutamergic excitatory input from the nucleus tractus 
solitarius (Seller 1991, Potts 2006). Hence the tonic sympatho-excitatory transmission 
from rVLM to sympathetic preganglionic fibers is modulated by the degree of inhibitory 
drive from cVLM neurons which in turn are under the control of the nucleus tractus 
solitarius (Reis et al. 1988, Seller 1991, Potts 2006).  
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2.4 THE FACTORS MODULATING HEART RATE RESPONSE TO NEURAL 
STIMULATION 
 
A complex interaction between sympathetic and vagal activity may be more important in 
the modulation of the HR than either branch alone (Camm and Fei 1996a). Postganglionic 
sympathetic and vagal fibers often lie side by side in the walls of the heart (Ehinger et al. 
1970, Levy and Martin 1979). Therefore, the neurotransmitters and neuromodulators 
released from nerve fibers of one autonomic division can influence the release of 
transmitters from the nerve endings of the other division (Levy and Martin 1979, Levy et 
al. 1981). When both divisions of the autonomic nervous system are stimulated 
simultaneously, the resultant cardiac effect is often different from the algebraic sum of the 
individual responses obtained by stimulating the nerves from the two divisions separately 
(Levy 1971, Levy and Martin 1979). A prominent feature of such cardiac autonomic 
interactions is that the vagal effects tend to predominate over the sympathetic effects with 
respect to the control of HR (accentuated antagonism) (Levy 1971, Levy and Martin 1979, 
Mendelowitz 1999). Two major mechanisms have been suggested for the explanations for 
the antagonist effects of vagal stimulation on sympathetically induced responses (Levy 
1971, Levy and Martin 1979, Mendelowitz 1999). The first is a presynaptic mechanism, in 
which acetylcholine reduces the amount of noradrenaline released from sympathetic nerve 
terminals (Starke 1977, Levy and Martin 1979, Mendelowitz 1999). The second is a 
postsynaptic mechanism, in which acetylcholine reduces the magnitude of the response to 
a given adrenergic stimulus (Levy 1971, Levy and Martin 1979, Mendelowitz 1999). This 
second mechanism presumably involves inhibitory Gi-protein-dependent inhibition of 
cyclic adenosine monophosphate synthesis (DiFrancesco and Tromba 1988, Mendelowitz 
1999).  
 
On the other hand, intense sympathetic stimulation attenuates the chronotropic responses to 
vagal stimulation in that case when sympathetic stimulation antecedes vagal stimulation 
(Yang and Levy 1992). This profound inhibition of vagal efficacy by antecedent 
sympathetic activity is believed to be mediated by the release of a specific neuromodulator, 
neuropeptide Y, from the sympathetic nerve endings (Warner and Levy 1989). 
Neuropeptide Y inhibits acetylcholine release from vagal nerve endings (Yang and Levy 
1992). Additionally, catecholamines can reduce the release acetylcholine by binding to α-
adrenergic receptors in the presynaptic region of the parasympathetic nerve fibers (Åstrand 
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et al. 2003). Finally, a high concentration of noradrenaline released into the synaptic cleft 
by a sympathetic postganglionic fiber may limit the subsequent release of further 
noradrenaline through binding to α2-receptors on the presynaptic nerve terminal (a negative 
feedback mechanism) (Hammond and Froelicher 1985, Åstrand et al. 2003).   
 
Opioids modulate parasympathetic control of HR via receptors at the SA node (Farias et al. 
2001), or prejunctionally on vagal nerve terminals (Caffrey 1999) or within nearby 
parasympathetic ganglia (Caffrey 1999) resulting in attenuation of vagally mediated 
bradycardia.    
 
Besides pre- and postsynaptic interactions described above, processing probably occurs 
within intrinsic cardiac nervous system which involves afferent neurones, local 
interconnecting neurones as well as both parasympathetic and sympathetic efferent 
postganglionic neurones (Armour 1999). Intrinsic cardiac ganglionic interactions represent 
the organ component of the hierarchy of intrathoracic nested feedback control loops which 
provide rapid and appropriate reflex coordination of efferent autonomic outflow to the 
heart (Armour 1999). 
 
The chronotropic response of the SA node to a fixed neuronal stimulus can vary as a result 
of the change in receptors number and activity (Opie 1991). The number of receptors per 
unit area of the SA node sarcolemma (the receptor density) is not fixed but can rise or fall 
in response to certain physiological or pathophysiological circumstances, the processes 
called up- and downregulation (Opie 1991). For example, in the congestive heart failure 
there is a chronic high-level exposure to catecholamines which incurs reduction in the 
number of β1-receptors, while β2-receptor density remains constant (Bristow et al. 1990, 
Horn and Bilezikian 1990, Opie 1991). The second form of the changed response is 
uncoupling which refers to a state of the receptor where there is no loss in density, but 
functional activity is diminished (Bristow et al. 1990). The underlying molecular 
mechanisms of uncoupling are the increased level of inhibitory Gi-protein leading to a 
reduced ratio Gs/Gi, as well as an impaired Gs-mediated coupling between β-receptor and 
adenylate cyclase (Bristow et al. 1990, Horn and Bilezikian 1990). The third form of the 
changed response is a change in receptor affinity (Opie 1991). For example, β-agonist 
catecholamines induce or stabilize a high affinity form of the β-adrenergic receptor, which 
is specific for agonists and binds antagonists rather weakly (Opie 1991).  
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The chronotropic response of SA node to a neural stimulation also involves genetic 
variation which is yet poorly known (Hautala et al. 2006, Nieminen et al. 2006, Snyder et 
al. 2006). Arg389Gly polymorphism of the β1-adrenergic receptor is associated with 
difference in HR at rest (Bengtsson et al. 2001, Humma et al. 2001) but not during exercise 
(Buscher et al. 2001, Xie et al. 2001, Leineweber et al. 2004). Gene GNAS1 encodes α-
subunit of the stimulatory G-protein that couples β1-adrenergic receptor with the adenylyl 
cyclase (Nieminen et al. 2006). T393C polymorphism of GNAS1 modulates HR response 
when values at rest, maximal exercise and recovery are considered together (Nieminen et 
al. 2006). Arg16Gly polymorphism of the β2-adrenergic receptor is associated with 
difference in HR at rest but during low or high intensity exercise the difference in HR does 
not persist between genotypes (Snyder et al. 2006). The rs324640 polymorphism of the 
muscarinic M2-receptor gene is associated with difference in HR recovery after exercise 
but maximal HR is not different between the genotypes (Hautala et al. 2006).   
 
2.5 THE MECHANISMS CONTROLLING HEART RATE  
 
Although easily measured, the HR reflects a complex, integrated physiologic response: 
autonomic tone, central and peripheral reflexes, hormonal influences, and factors intrinsic 
to the heart are all important (Figure 1) (Hammond and Froelicher 1985, Hainsworth 1995, 
Iellamo 2001). Some reflexes may increase HR through a decrease in vagal tone, an 
increase in sympathetic activity, or both, whereas others exert the opposite effects 
(Hainsworth 1995, Iellamo 2001). In the intact human cardiovascular system several 
reflexes and control mechanisms operate simultaneously, and the interactions are quite 
complex (Hainsworth 1995, Iellamo 2001). The relative importance of neural control 
mechanisms in determining the cardiovascular response to exercise is dependent upon the 
type of exercise (static or dynamic), the intensity of the exercise, the time after the onset of 
exercise (immediate, steady state, exhaustion, etc.), and the effectiveness of blood flow to 
meet the increased metabolic needs of the contracting muscle (Mitchell 1990, Iellamo 
2001). Different control mechanisms for cardiovascular response during exercise are 
somewhat redundant, rather than additive, and they impinge on the same regulatory 
neurons in the vasomotor center of medulla, and, possibly, other sites, where integration of 
afferent information occurs (Mitchell 1990, Waldrop et al. 1996). Besides neurally 
mediated reflexes, some humoral factors, such as cortisol, glucagon, growth hormone and 
 21
thyroxine may play a minor modifying at the control of HR (Hammond and Froelicher 
1985, Berne and Levy 1988, Camm and Fei 1996a).  
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Figure 1. The overview of mechanisms influencing heart rate. See text for the more detailed discussion about 
the effects mediated by each individual mechanism.  
 
2.5.1 Arterial baroreceptors and cardiopulmonary low-pressure baroreceptors 
The function of the arterial baroreceptors is to maintain a normal BP (Kirchheim 1976, 
Raven et al. 1997, Raven et al. 2002). The arterial baroreceptors include carotid and aortic 
baroreceptors which are spray-type nerve endings located in the walls of several of the 
large arteries (Shields 1993, Camm and Fei 1996a, Raven et al. 2002). Carotid receptors lie 
in the wall of the internal carotid artery on either side (Joyner and Shepherd 1991, 
Hainsworth 1995, Camm and Fei 1996a). Each send impulses centrally in the sinus nerve 
(of Hering), a branch of the glossopharyngeal nerve (Joyner and Shepherd 1991, Shields 
1993, O'Leary and Potts 2006). Aortic arch receptors on the left are close to the aortic arch, 
but those to the right lie at the origin of the right subclavian artery and in the adjacent 
regions of the brachiocephalic artery (Joyner and Shepherd 1991, Camm and Fei 1996a, 
De Sutter et al. 2006). From the aortic receptors, activity travels centrally in small vagal 
branches (Joyner and Shepherd 1991, Shields 1993, O'Leary and Potts 2006). The nerve 
endings in the carotid sinus and aortic arch are activated by expansion of the arterial wall 
when BP is increased, and this stretching result in increases in discharge frequency in their 
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afferent nerves (arterial baroreflex) (Raven et al. 1997, Raven et al. 2002, De Sutter et al. 
2006). Afferent nerves transmit the baroreceptor activity to the nucleus tractus solitarius 
which modulates autonomic outflow to buffer the rise in pressure (Hainsworth 1995, 
Camm and Fei 1996a, Raven et al. 2002). Conversely, a fall in BP reduces baroreceptor 
discharge and trigger adjustments that oppose the hypotension (Hainsworth 1995, Raven et 
al. 1997, Raven et al. 2002). The baroreceptors respond much more to a rapidly changing 
pulsatile pressure than to a stationary pressure (Guyton and Hall 1996, Åstrand et al. 
2003). In dogs, arterial rhepreceptors has been identified in the carotid sinus that respond 
to increased blood flow by sensitizing the function of baroreceptors (Hajduczok et al. 
1988). The existence of rheoreceptors in humans, not to speak of their role in regulation of 
HR, is not known.       
 
Because mean arterial BP equals cardiac output times total peripheral resistance, the 
nucleus tractus solitarius can induce changes in BP by affecting either cardiac output, total 
peripheral resistance, or both of them via modulation of neural output (Rowell 1993, 
Raven et al. 1997, Seals 2006). In hypertensive stimulus there is a rapid decrease in HR 
due to increased vagal discharge to the heart (Scher et al. 1991, Rowell 1993, O'Leary and 
Potts 2006). In hypotensive stimulus there is an initial rapid increase in HR with 
withdrawal of vagal tone but now accompanied by a slower rise in HR due to increased 
sympathetic discharge (Scher et al. 1991, Rowell 1993, O'Leary and Potts 2006). The 
increase in total peripheral resistance (vasoconstriction) plays a major role in hypotensive 
stimulus whereas in hypertensive stimulus a decrease in HR is more important (Scher et al. 
1991, Rowell 1993). At rest roughly one third of the changes in arterial BP during carotid 
baroreceptor stimulation are due to changes in HR and two-thirds are dependent on 
alterations in total peripheral resistance but the corresponding estimate for the overall 
baroreflex (carotid and aortic parts combined) is not known (Ogoh et al. 2003). Previously 
it was assumed that aortic baroreceptors operates over a higher range of arterial pressures 
than carotid receptors (Sagawa 1983, Hainsworth 1995, Guyton and Hall 1996) but more 
recent studies have shown that both baroreceptor populations operate over the same range 
of pressures (Smith et al. 2001). The estimated contribution of carotid baroreflex to overall 
baroreflex control is from 30% to 50 % (Smith et al. 2001, Fadel et al. 2003). Aortic and 
carotid baroreceptors summate in their reflex effects (Scher et al. 1991, Hainsworth 1995). 
Because the relationship between total baroreceptor input and response is sigmoid, the type 
of summation (linear, inhibitory or facilitatory) depends critically on the size of the 
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stimulus as well as the magnitude of the step in pressure to the baroreceptors (Yamazaki 
and Sagawa 1989, Scher et al. 1991, Hainsworth 1995). 
 
The fact that during exercise BP and HR rise linearly with increases in work rate whereas 
at rest the corresponding increases would induce powerful opposing reflexes by baroreflex 
has puzzled physiologists for over a century (Zuntz and Geppert 1886, Krogh and Lindhard 
1917). The current view is that the arterial baroreflex is reset in direct relation to the 
intensity of dynamic exercise without a change in sensitivity of the reflex (Potts et al. 
1993, Papelier et al. 1994, Norton et al. 1999). The resetting moves the baroreflex set point 
to the higher BP level so that baroreflex does not oppose the rising arterial BP but even 
actively tries to elevate BP (via further vagal withdrawal and/or sympathetic excitation to 
the heart and/or sympathetically mediated vasoconstriction) until the new set point is 
achieved (Rowell and O'Leary 1990, Joyner 2006, Raven et al. 2006). During exercise 
changes in arterial BP during carotid baroreceptor stimulation are mostly due to changes in 
total peripheral resistance so that only at light workload HR contributes to changes in BP 
(Collins et al. 2001, Raven et al. 2006). The central command is probably the primary 
regulator of baroreflex resetting during exercise (Gallagher et al. 2001b, Gallagher et al. 
2006, Raven et al. 2006). Muscle chemoreflex is capable to reset baroreflex as well but in 
normal dynamic exercise it acts more as a modulator of central command-induced resetting 
(Gallagher et al. 2001a, Gallagher et al. 2006, Raven et al. 2006). 
 
Cardiopulmonary low-pressure baroreceptors monitor cardiopulmonary blood volume by 
sensing changes in the filling pressure of the chambers of the heart and pulmonary arteries 
and veins, as well as cardiac contractility and afterload (Rowell 1993, Rowell et al. 1996, 
Ray and Saito 2000). Increases in these stimuli activate mechanically sensitive receptors in 
these structures, stimulating vagal afferent fibers that signal the nucleus tractus solitarius to 
inhibit sympathetic nervous system activity (Rowell 1993, Ray and Saito 2000, Seals 
2006). The latter results in systemic vasodilatation and a reduction in total peripheral 
resistance, but physiological changes in cardiopulmonary low-pressure receptor activity 
cause little if any change in HR (Rowell 1993, Ray and Saito 2000, Seals 2006). When 
central venous pressure is normal cardiopulmonary low-pressure baroreceptors tonically 
inhibit vasoconstriction induced by arterial baroreflex (Rowell 1993, Raven et al. 2000, 
Ray and Saito 2000). 
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The cardiopulmonary low-pressure baroreceptors are not reset by central nervous system 
during exercise, but they continuously inhibit arterial baroreceptor induced 
vasoconstriction (Rowell 1993, Raven et al. 1997, Ray and Saito 2000). If this tonic 
inhibition is eliminated by lower body negative pressure during exercise at a fixed 
workload mean arterial BP and HR do not change, but total peripheral resistance increases 
and stroke volume decreases (Mack et al. 1988). Likewise, the cardiopulmonary low-
pressure baroreceptors inhibit the muscle metaboreflex-mediated vasoconstriction during 
dynamic exercise (Collins and DiCarlo 1993).  
 
2.5.2 Central command and peripheral afferents  
Central command is the term for motor command signals originating from subthalamic 
neurons involved in locomotion which is believed to be a primary stimulus mediating the 
autonomic nervous system adjustments to exercise (Rowell 1980, Raven et al. 1997, Delp 
and O'Leary 2004). These signals activate separately both somatomotor and cardiovascular 
control systems at the onset of exercise (Mitchell 1990, Rowell 1992, Delp and O'Leary 
2004). Activation is in direct proportion to the number of motor units required to maintain 
a given force of contraction (Rowell 1992, Rowell 1993, Rowell et al. 1996). The 
magnitude of a central command- mediated cardiovascular response during exercise can be 
independent of force production (e.g. imagined exercise) and dictated more by an 
individual’s perception of effort (Rowell 1993, Waldrop et al. 1996, Nowak et al. 2005). 
Central command increases HR, cardiac output, and also BP immediately at the onset of 
exercise by rapid vagal withdrawal but command signals have minimal effect on the 
sympathetic nervous system mediated vasoconstriction (Rowell 1992, Waldrop et al. 1996, 
Waldrop and Kramer 2000). Because both locomotor and cardiovascular responses, much 
like those to exercise, can be induced by either electrical or chemical stimulation of cells in 
hypothalamic locomotor region and in mesencephalic locomotor region, the current view is 
that these two neuroanatomical areas are strongly involved in the central command 
(Mitchell 1990, Waldrop et al. 1996, Waldrop and Kramer 2000). Both these areas have 
connections with the vasomotor center in medulla which enables them to affect the 
cardiovascular control (Rowell 1993, Waldrop et al. 1996, Waldrop and Kramer 2000).  
 
Originally it was thought that the central command acts as a pure feed-forward control 
mechanism (Rowell 1993, Rowell et al. 1996). The close relationship of the central 
command with the number of motor units recruited, or with the perception of effort 
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suggests an important role for feedback from exercising muscles (Rowell 1993, Seals 
2006, Williamson et al. 2006). Brain mapping studies have showed that two regions of the 
cerebral cortex, the insular cortex and the medial prefrontal cortex, may function to 
interpret feedback signals from active muscles and elicit appropriate autonomic 
adjustments via connections to the vasomotor center (Williamson et al. 2006).  
 
Muscle chemoreflex are elicited from chemosensitive group III and IV afferent fibers in 
the muscle whenever muscle blood flow falls below the critical level needed to maintain 
adequate oxygen transport to the muscle (Rowell 1980, Rowell 1992, Kaufman and Hayes 
2002). Release of hydrogen from the working muscles might signal the onset of the reflex, 
it may actually stimulate not chemically sensitive afferents but rather the conversion of 
monoprotonated phosphate to its diprotonated form (Kaufman and Forster 1996, Rowell et 
al. 1996). Excitatory action potentials from muscle sensory afferents project to the brain 
via synaptic transmissions in the dorsal root of the spinal cord (Mitchell 1990, Kaufman 
and Hayes 2002, Seals 2006). This exerts effects on the vasomotor center in medulla 
(primarily cVLM and rVLM), which in turn inhibit vagal and/or stimulate sympathetic 
preganglionic neurons, thus producing efferent autonomic nervous system responses to the 
heart and arterial vasculature (Mitchell 1990, Kaufman and Hayes 2002, Seals 2006). The 
muscle chemoreflex has a distinct threshold, and in mild exercise this reflex is not tonically 
active (Rowell 1992, Rowell 1993, Rowell et al. 1996). As the severity of exercise 
increases to moderate, the margin for any blood flow error decreases, and the reflex is 
tonically active (Rowell 1993, Rowell et al. 1996). The baroreflex normally buffers the 
muscle chemoreflex by limiting chemoreflex-induced peripheral vasoconstriction so that 
the rise in arterial BP by the muscle chemoreflex occurs almost solely via an increase in 
cardiac output (i.e. rise in HR) (O'Leary 2006).  
 
Besides chemosensitive fibers group III and IV afferent fibers in muscle contain 
mechanosensitive fibers as well (Rowell 1980, Mitchell 1990, Kaufman and Hayes 2002). 
These fibers are excited by mechanical stimuli (stretch and/or compression) in the active 
muscle (Mitchell 1990, Kaufman and Hayes 2002, Seals 2006). Their role in control of HR 
is not well understood (O'Leary 1996, O'Leary and Potts 2006) but it has been shown that a 
passive cycling of the legs significantly increased HR above baseline within one second of 
the onset of limb movement (Nobrega and Araujo 1993). In studies utilizing static muscle 
contraction this fast tachycardic response is vagally mediated (McMahon and McWilliam 
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1992) but evidence also exists for a slower sympathetically mediated tachycardiac 
response induced by mechanosensitive fibers (Matsukawa et al. 1994). Since 
mechanoreceptor discharge quickly returns toward control levels during sustained static 
contractions, it is unlikely that these afferents contribute importantly to the maintained 
tachycardia in static exercise (O'Leary 1996). It is not known, however, whether this 
waning occurs to a same extent during dynamic contractions as well (Rowell 1993). 
Nevertheless, the muscle-heart reflex is not necessary for the vagally mediated increase in 
HR that occurs at the onset of exercise; this increase has been shown to be evoked by 
attempted exercise in subjects paralyzed with curare-like drugs (i.e. an absent afferent 
input from muscles) (Leonard et al. 1985). 
 
In addition to responding to chemical and/or mechanical stimuli, many group III and IV 
sensory afferents are thermosensitive (Rowell 1993, Kaufman and Forster 1996, Rowell et 
al. 1996). Because muscle temperature, which is normally well below 37°C in the limbs, 
can increase beyond 40°C during severe exercise (Rowell 1993, Rowell et al. 1996). Thus, 
it is possible that these afferents could be stimulated and provide feedback to the central 
nervous system regarding the thermal status of the active muscle fibers (Rowell 1993, 
Rowell et al. 1996). While this remains a possibility, experimental findings are insufficient 
to determine the role of this mechanism in autonomic nervous system-mediated 
cardiovascular control during exercise (Rowell 1993, Seals 2006). 
 
2.5.3 Respiratory sinus arrhythmia, arterial chemoreceptors, and pulmonary and 
cardiac receptors 
Respiratory sinus arrhythmia refers to the rhythmic variations HR, occurring at the 
frequency of respiration (Berne and Levy 1988, Hainsworth 1995, Mendelowitz 1999). 
Typically HR accelerates during inspiration and decelerates during expiration (Berne and 
Levy 1988, Hainsworth 1995, Mendelowitz 1999) as a result of complex central and reflex 
intearactions involving both vagal and sympathetic branches of autonomic nervous system 
(Taylor et al. 2001). During exercise respiratory sinus arrhythmia gradually disappears 
despite gradually increasing respiration (Arai et al. 1989, Tulppo et al. 1996).  
 
Peripheral arterial chemoreceptors are situated in the aortic and carotid bodies (Shields 
1993, Hainsworth 1995, Camm and Fei 1996a). They excite nerve fibers that pass through 
carotid nerves and the vagus nerves into vasomotor center (Spyer 1990, Shields 1993, 
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Guyton and Hall 1996). Activity in their afferent nerves is increased by arterial hypoxia, 
hypercapnia, or acidemia (Sampson and Hainsworth 1972, Shields 1993, Camm and Fei 
1996a). The primary effect of aortic body chemoreceptor stimulation on HR is excitatory 
(Karim et al. 1980). Conversely, carotid chemoreceptor stimulation causes a large and 
consistent bradycardia, but with intact respiratory control it is normally counterbalanced by 
tachycardia accompanying respiratory response induced by the same stimulation 
(Hainsworth et al. 1973, Berne and Levy 1988, Camm and Fei 1996a). Because exercise 
normally is associated with maintenance of PaO2, normal or reduced arterial carbon 
dioxide, and maintenance of blood pH within acceptable limits, the arterial chemoreceptors 
are not normally activated and therefore likely do not play an important role in HR control 
during conventional dynamic exercise at sea level (Hammond and Froelicher 1985, Seals 
2006). 
 
The lungs are richly innervated and lung inflation, with moderate pressures, stimulates 
airways stretch receptors which results in a reflex increase in HR (Hainsworth 1974, 
Coleridge and Coleridge 1991). The reflex response during hyperinflation of the lung and 
also during pulmonary congestion is to cause bradycardia (Hainsworth 1995). Because 
breathing frequency, tidal volume, and minute ventilation all increase during exercise, it is 
possible that reflexes activated by lung inflation participate in HR control during exercise 
but at present there is no compelling evidence for it (Seals 2006).  
 
Atrial receptors are concentrated near the junctions of the superior and inferior venae cavae 
and the pulmonary veins with the atria (Hammond and Froelicher 1985, Hainsworth 1995, 
Camm and Fei 1996a). The afferent fibers are contained in the vagus and the efferent 
pathway within the sympathetic nerves (Hainsworth 1991, Hainsworth 1995, Camm and 
Fei 1996a). Atrial receptors are stimulated mainly by stretching due to increases in atrial 
volume which results in a reflex increase in HR (Hammond and Froelicher 1985, 
Hainsworth 1995, Camm and Fei 1996a). Because of the relatively slow time-course of 
sympathetic responses, the tachycardia to stimulation of atrial receptors requires up to 30 
seconds to reach a stable level (Hainsworth 1995).  
 
Some authors suggest that a larger stimulation of atrial receptors via the increased venous 
return during exercise may be an important mechanism mediating a normal exercise-
induced tachycardia (Hainsworth 1991, Wilkoff and Miller 1992, Åstrand et al. 2003). On 
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the contrary, the other authors conclude that the tachycardic reflex mediated by the atrial 
receptors is weak or nonexistent in humans and thus it does not play any role in exercise-
induced tachycardia (Rowell 1993). A direct stretch of SA node can also increase HR to 
some extent and this mechanism may be operative in exercise when venous return is 
increased (Shephard 1993, Guyton and Hall 1996). The mechanism might be augmented 
after heart transplantation (Shephard 1993, Camm and Fei 1996a) but in the normal heart 
this mechanism is largely masked or overridden by other reflex mechanisms (Blinks 1956). 
A rise in the temperature of the blood reaching SA node as the consequence of muscular 
work may also increase HR via a direct effect on SA nodal tissue (Shephard 1993, Guyton 
and Hall 1996). 
 
Ventricular mechanoreceptors are situated mainly in the left ventricle and the afferent 
nerves travel either in the vagus or in the sympathetic nerves (Hainsworth 1991, Thames et 
al. 1993). Both populations of receptors can be divided into mechanosensitive and 
chemosensitive endings (Hainsworth 1991, Thames et al. 1993). Normally their activity 
does not modulate HR either at rest or during exercise but in the ischemic myocardium 
their activation results in powerful reflex responses (Thames et al. 1993, Hainsworth 1995, 
Armour 1999). The vagal afferents mediate reflex cardio-inhibitory, sympatho-inhibitory, 
vasodepressor responses while activation of sympathetic afferents results in cardio-
accelerator, sympatho-excitatory, vasodepressor responses (Hainsworth 1991, Thames et 
al. 1993). Both mechanical and chemical stimuli may be involved in activation of 
receptors, but chemical stimuli are more important for triggering of reflexes (Hainsworth 
1991, Thames et al. 1993, Hainsworth 1995). The anginal pain is mediated by sympathetic 
afferent fibers and causes tachycardia (Hainsworth 1991, Thames et al. 1993, Hainsworth 
1995). The vagal afferents are located nearer to the endocardial than to the epicardial 
surface while the reverse is true for the sympathetic afferents (Thames et al. 1993). Thus 
subendocardial ischemia stimulates vagal afferents resulting in bradycardia whereas 
transmural ischemia more likely induces tachycardia mediated by sympathetic afferents 
(Thames et al. 1993). Left ventricular vagal afferents are preferentially distributed to the 
inferoposterior wall whereas sympathetic afferents appear to be more uniformly distributed 
throughout the wall of the left ventricle (Thames et al. 1993). This probably explains why 
bradycardia usually occurs when the circumflex branch is occluded or when ischemia 
involves the inferior and lateral wall of the left ventricle (Hainsworth 1991, Thames et al. 
1993). Occlusion of the anterior descending branch or ischemia involving anterior wall is 
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likely to result in increase in HR (Hainsworth 1991, Thames et al. 1993). The chemical 
stimuli which activate receptors involve substances resulting from myocardial ischemia 
including bradykinin, prostaglandins and adenosine (Hainsworth 1991, Thames et al. 
1993). The bulging or dyskinesis of the ischemic zone may stimulate mechanosensitive 
vagal afferents but the increase in discharge lasts only approximately two minutes whereas 
the increased discharge of chemosensitive vagal afferent persists for the duration of the 
ischemic event (Thames et al. 1993). 
 
2.6. HEART RATE RESPONSE TO EXERCISE: A SYNTHESIS 
 
In 1990 Rowell & O’Leary introduced an overall model as to how the autonomic nervous 
system adjustments to large-muscle dynamic exercise may be mediated (Rowell and 
O'Leary 1990). This hypothesis represents the most compelling integrative scheme 
attempting to explain the primary signals involved and how those signals may interact to 
produce autonomic nervous system adjustments to exercise (Seals 2006). The key concept 
in the model is that BP is the primary variable controlled during exercise and control of HR 
serves as an adjunct in this scheme (Rowell and O'Leary 1990, Rowell 1991, Rowell 
1992).  
 
From a resting value up to a rate of 100 beats/min during dynamic upright exercise HR 
increases rapidly primarily due to the activation of vagal withdrawal (Ekblom et al. 1973, 
Freeman et al. 2006, Chaitman 2007). The activation of vagal withdrawal is mainly due to 
augmented central command (Rowell and O'Leary 1990, Rowell 1992, O'Leary 1996). 
Central command also resets the arterial baroreflex immediately to a higher operating point 
but normally the baroreflex does not elicit an increase in sympathetic nervous system 
activity because the rise in cardiac output (due to fast HR increase) is rapid enough to raise 
arterial BP to its new operating point (Rowell and O'Leary 1990, Rowell 1991, O'Leary 
1996). If any difference between the prevailing level of BP and a new, higher baroreflex 
operating point is detected by baroreceptors they can raise HR via further inhibition of 
parasympathetic tone (Rowell and O'Leary 1990, Rowell 1992, O'Leary 1996). In this 
setting the muscle chemoreflex is not activated, the exact role of the afferents from muscle 
mechanreceptors is unknown but in all probability their effect is negligible (Rowell and 
O'Leary 1990, Rowell 1992, O'Leary 1996).  
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During moderate exercise, when HR exceeds 100 beats/min, the activation of vagal 
withdrawal by central command still increases cardiac output, but not enough (Rowell and 
O'Leary 1990, Rowell 1991, Rowell 1992). The fast vagal component of the rise in cardiac 
output is not sufficient to raise cardiac output to a level that is needed to compensate fully 
the vasodilation in active muscle (Rowell and O'Leary 1990, Rowell 1991, Rowell 1992). 
Consequently, arterial BP cannot be increased immediately to its new, reset operating point 
so there is a pressure error detected by baroreceptors (Rowell and O'Leary 1990, Rowell 
1991, Rowell 1992). As a consequence of this error, sympathetic nervous system activity 
to both the heart and to the resistance vessels increases in order to correct the pressure error 
(Rowell and O'Leary 1990, Rowell 1991, Rowell 1992). The sympathetically mediated 
increase in HR and cardiac output is much slower (by 15- to 20-fold) than the 
parasympathetically mediated rise (Rowell and O'Leary 1990, Rowell 1991, Rowell 1992). 
Thus vasoconstriction in resistance vessels all over the body (including active skeletal 
muscle) becomes a necessary adjunct to increased cardiac output in order to raise arterial 
BP as quickly as possible to minimize the pressor error (Rowell and O'Leary 1990, Rowell 
1991, Rowell 1992). As workload increases, HR increases due to further sympathetic 
nervous system activation (Hammond and Froelicher 1985, Tulppo et al. 1996, Chaitman 
2007). The increase in sympathetic nervous system activity can occur due to the arterial 
barofeflex (via further baroreflex resetting), the muscle chemoreflex (after a threshold has 
been passed after which this reflex becomes tonically active), or muscle mechanoreceptor 
activation (Hammond and Froelicher 1985, Rowell 1992, O'Leary 1996). Besides direct 
neural excitation SA node is also stimulated by increased level of circulating adrenaline 
which is secreted from the adrenal medulla (Kjaer 1989, Lauer 2001c, Chaitman 2007). 
Adrenaline secretion is increased only during moderate to heavy exercise (typically 50% of 
maximal oxygen consumption or above) and sympathoadrenal activation becomes 
progressively greater as exercise intensity increases up to maximum (Kjaer 1989, Mazzeo 
1991, McArdle et al. 2001). As exercise approaches maximal levels, parasympathetic 
activity wanes and sympathetic nervous system activity increases such that at maximal 
oxygen consumption (VO2max) little parasympathetic tone remains and sympathetic activity 
is greatly elevated (Rowell and O'Leary 1990, O'Leary 1996, Tulppo et al. 1996). As 
during severe exercise HR is at or near maximal level, any further pressor response (i.e. to 
a fall in a baroreceptor activity or further muscle afferent activation) can only occur via 
peripheral vasoconstriction in that cardiac output is already at maximal levels (Rowell and 
O'Leary 1990, O'Leary 1996, O'Leary and Potts 2006). 
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Pharmacological blockade studies have proved the differential contributions of the two 
autonomic branches during exercise (Rosenwinkel et al. 2001). Blockade of vagal control 
with atropine (muscarinic receptor antagonist) reveals that most of the initial response to 
exercise, up to a HR of approximately 100 beats/min, is attributable to the withdrawal of 
tonic vagal activity (Craig 1952, Tulppo et al. 1996, Rohrer et al. 1998). Withdrawal of 
vagal tone has been confirmed using time and frequency domain analyses of HR variability 
as well (Arai et al. 1989, Tulppo et al. 1996). Conversely, blockade of sympathetic control 
with β-adrenergic receptor antagonist reveals the importance of augmented sympathetic 
activity during moderate and heavy exercise (Epstein et al. 1965, Brown et al. 1986, 
Hespel et al. 1986). During light exercise, with workloads of 25% to 40% of VO2max, 
plasma noradrenaline levels or directly measured muscle sympathetic nervous activity do 
not significantly increase, confirming the finding that the sympathetic nervous system is 
more important in the later stages of exercise (Rowell and O'Leary 1990, Rowell 1991, 
Rowell 1992).  
 
2.7 THE CENTRAL CIRCULATORY RESPONSE TO EXERCISE 
 
During dynamic upright exercise cardiac output (i.e. stroke volume times HR) increases 
somewhat linearly in proportion to the oxygen consumption (VO2), approximately 6 l/min 
of cardiac output per 1 l/min of VO2 (Bevegård et al. 1963, Wilkoff and Miller 1992, 
Navare and Thompson 2003). An appropriate increase of HR contributes significantly to 
attaining high levels of cardiac output (Stone and Liang 1984, Camm and Fei 1996a, Lauer 
2001c). Of the two major components of cardiac output, HR and stroke volume, HR is 
responsible for approximately two thirds of the total increase in cardiac output during 
dynamic upright exercise (Poliner et al. 1980, Iskandrian et al. 1983, Froelicher and Myers 
2006). When a normal human exercises maximally in upright position, the HR increase is 
150-300% of resting while the stroke volume increase is about 10-100% (Mitchell et al. 
1958, Plotnick et al. 1986, Camm and Fei 1996a). The stroke volume normally reaches its 
maximum or almost maximum by the time the cardiac output has increased only halfway 
to its maximum after which any further increase in cardiac output must occur by increasing 
the HR (Saltin 1964, Fletcher et al. 2001, Navare and Thompson 2003). Thereafter stroke 
volume levels off (Stenberg et al. 1967, Gledhill et al. 1994, Seals et al. 1994) or there is a 
small decline (Higginbotham et al. 1986, Seals et al. 1994, Stratton et al. 1994) or 
increment (Åstrand et al. 1964, Zhou et al. 2001, Martino et al. 2002) at maximal work 
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intensity. An increase in HR accompanying dynamic exercise results in an increase in the 
force of myocardial contraction as well (i.e. frequency-force-relationship or the staircase 
phenomenon) (Hammond and Froelicher 1985, Rowell et al. 1996, Moore 2006). The 
increase in force is secondary to a transient imbalance in cellular Ca2+ influx and efflux 
(favoring influx), an increase in sarcoplasmic reticulum Ca2+ content, and a larger 
sarcoplasmic reticulum Ca2+ release during each excitation-contraction coupling cycle 
(Rowell 1993, Rowell et al. 1996, Moore 2006). Although sufficient increase of HR is 
essential in order to raise cardiac output at heavier workloads, the absolute cardiac output 
which a person can attain is determined, however, by the magnitude of maximal stroke 
volume (Bevegård et al. 1963, Rowell 1974, Blomqvist and Saltin 1983). 
 
The relationship between HR and VO2 or work intensity is somewhat linear (Åstrand 1960, 
Lauer 2001a, Navare and Thompson 2003). It has been suggested that the HR might 
increase relatively less than VO2 as the work rate becomes very heavy (Bates 1967, Brooke 
et al. 1969, Wilkoff and Miller 1992) but two studies have shown the opposite (Treese et 
al. 1993, Lewalter et al. 1995). In both studies HR rose slightly more steeply above 
anaerobic threshold (approximately 50-60% of VO2max) than below anaerobic threshold but 
the HR/work intensity -relationship was linear (Lewalter et al. 1995).  
 
The linear relationship between HR and VO2 or work intensity is widely employed in a 
number of submaximal exercise tests (Åstrand and Ryhming 1954, Åstrand 1960, Maritz et 
al. 1961, Margaria et al. 1965, von Dobeln et al. 1967, Shephard et al. 1976, Siconolfi et al. 
1982, Siconolfi et al. 1985, Kline et al. 1987, Golding et al. 1989, Ebbeling et al. 1991, Oja 
et al. 1991), in which VO2max is estimated based on HR measured in a single or several 
submaximal workloads (Lange Andersen et al. 1971, McArdle et al. 2001, Åstrand et al. 
2003). By utilizing a linear HR-workload relationship a straight line is fitted to measured 
HR values (Lange Andersen et al. 1971, McArdle et al. 2001, Åstrand et al. 2003). This 
line is extrapolated to the predicted maximal HR; the corresponding estimated maximal 
workload can then be approximated (Lange Andersen et al. 1971, McArdle et al. 2001, 
Åstrand et al. 2003). VO2max can then be estimated by using the relationship between work 
rate and VO2 (Lange Andersen et al. 1971, McArdle et al. 2001, Åstrand et al. 2003). 
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2.8. THE FACTORS MODULATING HEART RATE RESPONSE TO EXERCISE 
 
In the same person under standardized conditions, the variation from day to day in HR at a 
given VO2 is 3-5 beats/min depending on the relative workload (%VO2max), provided the 
state of training is the same (Davies 1968, Jones and Kane 1979, Greiwe et al. 1995). The 
HR at a given VO2 is related to the maximal stroke volume (Jones and Campbell 1982, 
Ramamurthy et al. 1999) but it is no measure of maximal cardiorespiratory fitness unless 
the maximal HR is considered (Strandell 1964a, Åstrand et al. 2003). Despite limitation 
some researchers have, however, considered the workload which a person can attain at 
some predetermined HR as a good estimate of cardiorespiratory fitness (Wahlund 1948, 
Peters et al. 1983, Sobolski et al. 1987). There is a tendency for persons with a low resting 
HR to have a low HR at a fixed submaximal workload (Ekelund et al. 1988, Filipovsky et 
al. 1992, Blair et al. 1998) but this has not been observed consistently (Wilkoff and Miller 
1992, Sandvik et al. 1995). Concerning maximal HR, persons with a high maximal HR 
have a higher HR at the same relative workload compared with the persons with a low 
maximal HR (Åstrand 1967, Sandvik et al. 1995). Furthermore, an inverse (Blair et al. 
1998) or non-existent (Sandvik et al. 1995) relationship have been observed between 
maximal HR and HR at a fixed submaximal workload which emphasizes a fundamental 
difference when expressing a submaximal workload in terms of either relative or absolute 
work. 
 
The physiological limit on maximal HR in normal subject is determined by the steepness 
of the diastolic depolarization slope of SA nodal cells before they reach threshold potential, 
thus generating an action potential that is then propagated to surrounding cells (Guyton and 
Hall 1996, Awtry and Loscalzo 2001a). When HR reaches 195 beats/min in humans during 
severe exercise, ventricular diastolic filling time is only 0.12 seconds compared to 0.55 
seconds at rest (HR 70 beats/min) (Braunwald and Ross 1979, Oldershaw et al. 1983, 
Rowell et al. 1996). It seems logical that a limit would be approached where an increase in 
HR would not effectively increase cardiac output due to decreased diastolic filling; not 
only would the heart receive less blood to pump, but the degree of coronary artery 
perfusion would decrease (Hammond and Froelicher 1985, Froelicher and Myers 2006). 
Although this theoretical limitation is reasonable, there is little experimental work to 
support it (Åstrand et al. 1964, Hammond and Froelicher 1985, Froelicher and Myers 
2006).  
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Age. HR at a given submaximal VO2 (and workload) has been reported to be the same for 
individuals of the same gender and state of training regardless of age (Robinson 1939, 
Ekelund et al. 1988, Blair et al. 1998). On the other hand, HR at a fixed submaximal 
workload has also been suggested to be higher (Norris et al. 1953, Peters et al. 1983, 
Slattery and Jacobs 1988) or lower (Strandell 1964b, Jonsson and Astrand 1979, 
Filipovsky et al. 1992) in older subjects, but in these observations the state of training may 
differ between individuals. The decline of maximal HR with age is a well-known 
phenomenon (Lange Andersen et al. 1971, Tanaka et al. 2001, Higgins and Higgins 2007). 
A comprehensive review of the literature compiling over 23 000 subjects aged 5 to 81 
years revealed that age alone accounted for 75% of the variability in maximal HR; other 
factors added only about 5% (Londeree and Moeschberger 1982). Of mechanisms 
underlying age-related decrease in maximal HR, cardiac chronotropic responsiveness to β-
adrenoceptor stimulation has been shown to be preserved (Poldermans et al. 1995) or 
reduced (Conway et al. 1971, White et al. 1994, Esler et al. 1995) in the elderly. 
Subclinical atherosclerosis accompanying aging has been proposed as a mechanism as well 
(Åstrand et al. 2003). The slope of the decay of exercise maximal HR with age is very 
similar to the slope of the intrinsic HR with age suggesting that the decline of maximal HR 
is independent of autonomic influence but has more to do with the SA node and the 
myocardium (Kostis et al. 1982, Bruce 1984, Hammond and Froelicher 1985). Age-related 
decline in maximal HR is steeper in men with a low cardiorespiratory fitness (Cooper et al. 
1977) and physical inactivity (Froelicher and Myers 2006). 
 
Gender. HR at a given submaximal workload is higher in women (Åstrand 1952, Blair et 
al. 1998, Wilmore et al. 2001). Maximal HR does not differ between genders (Åstrand and 
Christensen 1964, Londeree and Moeschberger 1982, Froelicher and Myers 2006) or is 
slightly lower (Hermansen and Andersen 1965, Sidney et al. 1992, Blair et al. 1998) in 
women. Menstrual cycle. In women HR at a fixed submaximal workload has been 
reported to be higher during the mid-luteal phase (Pivarnik et al. 1992), but most studies 
have reported no change in submaximal (Jurkowski et al. 1981, De Souza et al. 1990, 
Smekal et al. 2007) or maximal HR (Dombovy et al. 1987, Lebrun et al. 1995, Smekal et 
al. 2007) over the menstrual cycle. 
 
Body height and weight. The persons with the heavier body weight have been reported to 
have a lower HR at a fixed submaximal workload (Jonsson and Astrand 1979, Jones and 
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Campbell 1982), and the association is more pronounced when lean body weight is 
considered instead of total body weight (Cotes et al. 1973, Spiro et al. 1974). Height and 
body weight (lean or total) do not affect on maximal HR (Jones and Campbell 1982, 
Hammond and Froelicher 1985, Freeman et al. 2006). Obesity. The overweight persons 
have a higher HR at a fixed submaximal workload than normal weight persons. The 
relationship is valid especially when exercising in treadmill but in cycle ergometer as well 
(Buskirk et al. 1955, Dempsey et al. 1966, Sidney et al. 1992). In two studies, however, 
there was no relationship between body mass index (BMI) and HR at a given submaximal 
workload in treadmill (Gordon et al. 1987, Ekelund et al. 1988), and in one study 
(Filipovsky et al. 1992) an inverse relationship was observed between BMI and HR at a 
given submaximal workload in cycle ergometer. Overweight has not been reported to have 
an effect on maximal HR (Dempsey et al. 1966, Hammond and Froelicher 1985, Freeman 
et al. 2006) except one study in which overweight was associated with lower maximal HR 
(McHenry et al. 1977). 
 
Mode of exercise. HR is slightly higher at a given submaximal VO2 in cycle ergometer 
compared with treadmill (Hermansen et al. 1970, Niederberger et al. 1974). Maximal HR 
probably does not differ between cycle ergometer and treadmill (Åstrand and Saltin 1961, 
Hermansen and Saltin 1969, Myers et al. 1991) although it has been suggested to be 
slightly lower with cycle ergometer testing (Wicks et al. 1978, Londeree and 
Moeschberger 1982, Camm and Fei 1996a). Both HR at a given submaximal workload and 
maximal HR are lower in work on a cycle ergometer in the supine position (Bevegård et al. 
1963, Hossack 1987, Camm and Fei 1996a). Total mass of working muscles. The HR at a 
given submaximal workload is higher when the dynamic exercise is performed with the 
arms than with the legs (Christensen 1931a; Pendergast 1989, Wilkoff and Miller 1992). 
The maximal HR with arm exercise is 88-100% from the maximal HR in leg exercise (De 
Boer et al. 1982, Balady et al. 1986, Wilkoff and Miller 1992). Exercise protocol. Large 
increments in workload combined with a short duration of the step may result in HR not 
rising to steady state level at that workload (Sietsema et al. 1989). Consequently, HR at 
that submaximal workload is lower than the actual HR at the identical work provided that 
steady state would have been achieved (Sietsema et al. 1989). The maximal HR is not 
markedly different between protocols as long as the same exercise mode is used 
(Froelicher et al. 1974, Myers et al. 1991). Pedal frequency. When exercising with cycle 
ergometer, HR at a fixed submaximal workload may be slightly lower with a pedal 
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frequency of 40 to 50 revolutions/minute compared with clearly higher pedal frequencies 
(Eckermann and Millahn 1967). 
 
Habituation. Habituation to repeated exercise tests has been found to lead to a reduction 
in HR response to a fixed submaximal workload, but the habituation effect is difficult to 
separate from a training response (Davies et al. 1970, Wolthuis et al. 1977). Other studies 
have, however, shown no appreciable habituation effect (Jones and Kane 1979). True 
maximal effort. Maximal effort should always be confirmed objectively before an attempt 
is made to measure a maximal HR (Camm and Fei 1996a). Objective measures of 
appropriate maximal effort include respiratory exchange ratio >1.10 and blood lactate level 
>7-8 mmol/l (Hammond and Froelicher 1985, Camm and Fei 1996a, Froelicher and Myers 
2006). Older individuals might be more afraid to achieve the true maximal exertion but this 
effect may disappear on repeated testing (Hammond and Froelicher 1985). Even if the true 
VO2max is achieved in exercise it is still possible that maximal HR is even slightly higher 
than HR measured at the workload corresponding to VO2max (Saltin et al. 1968). Sampling 
interval of HR measurement. The difference between measured HR and true HR 
(determined by the last 30 seconds of each minute during exercise) is inversely related to 
sampling interval (Atwood et al. 1989). The 6-second rhythm strip at the end of each 
minute represents a reasonable balance between convenience and precision for measuring 
HR during exercise (Atwood et al. 1989). 
 
Environment. A hot environment causes a higher HR at a fixed submaximal workload 
than exercise at a low ambient temperature (Rowell et al. 1966, Ward et al. 1987, Wilkoff 
and Miller 1992). Also a high relative humidity elicits a higher HR at a fixed submaximal 
workload (Wilmore and Costill 2004). Maximal HR can even reach slightly higher values 
under hyperthermia than in normothermia (Rowell 1993). Again, HR at a given 
submaximal workload is lower in a cold environment (Stevens et al. 1987) and also 
maximal HR is lower compared with neutral temperature (Nielsen Johannsen 2000). 
Emotional factors, nervousness, excitement and apprehension may raise the HR during 
exercise of light and moderate intensity (Lange Andersen et al. 1971, Wilkoff and Miller 
1992, Åstrand et al. 2003). The heavier the workload, however, the less pronounced is this 
nervous effect on the HR so that it does not affect maximal HR (Åstrand et al. 2003). 
Dehydration. In dehydrated state HR at a given submaximal workload is higher than in 
euhydrated state (Wilkoff and Miller 1992, Fletcher et al. 2001, Higgins and Higgins 2007) 
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whereas acute expansion of blood volume produces decreased HR (Fortney et al. 1981, 
Fortney et al. 1983, Hopper et al. 1988). Acute plasma volume expansion does not affect 
on maximal HR (Kanstrup and Ekblom 1982) but in dehydrated state maximal HR might 
be slightly higher than in euhydrated state (Rowell 1993).  
 
Level of fitness. HR at a fixed workload seems to be inversely related to a maximal 
cardiorespiratory performance of a subject (Christensen 1931b, Tavel 2001, Higgins and 
Higgins 2007), although maximal HR modulates this relationship (Åstrand et al. 2003). A 
high cardiorespiratory fitness accelerates the rate of attainment of the steady-state HR at 
submaximal work (Jones et al. 1970, Sietsema et al. 1989). Maximal HR has been reported 
to be the same (Åstrand 1956, Pollock 1977, Balady and Weiner 1987), higher (Grimby 
and Saltin 1966, Sandvik et al. 1995, Blair et al. 1998) or lower (Hermansen and Andersen 
1965, Lester et al. 1968, Londeree and Moeschberger 1982) in subjects with a high 
cardiorespiratory fitness.  
 
Training. Within a same subject endurance-typed exercise training reduces HR at a given 
submaximal workload and a reduced activity has an opposite effect (Karvonen et al. 1957, 
Camm and Fei 1996a, Moore and Palmer 1999). The rate of attainment of the steady-state 
HR at submaximal work occurs more rapidly after training as well (Hagberg et al. 1980). 
Endurance training does not change the maximal HR or slightly reduces it (Benestad 1965, 
Rerych et al. 1980, Spina et al. 1992). Cessation of endurance-typed exercise training may 
increase maximal HR (Coyle et al. 1984). HR at a given submaximal workload has been 
reported to be lower (Christensen 1931a; Ekelund et al. 1988, Sidney et al. 1992) and 
maximal HR higher (Sandvik et al. 1995), respectively, in subjects with a higher level of 
self-reported physical activity. Bed rest. After prolonged bed rest, HR at a given 
submaximal workload is higher than before bed rest (Saltin et al. 1968, Myers 1995, 
Fletcher et al. 2001). The maximal HR is either the same (Saltin et al. 1968) or increased 
after the bed rest (Convertino et al. 1982, Myers 1995). 
 
Medications and alcohol. The effects of various medications on HR during exercise are 
summarized in Table 1. After acute ingestion of alcohol, HR at a fixed submaximal 
workload is increased (Blomqvist et al. 1970) or unaltered (American College of Sports 
Medicine 2000) but maximal HR is not affected (Blomqvist et al. 1970).  
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Table 1. The medications affecting heart rate during exercise (Hammond and Froelicher 
1985, Kendrick et al. 1987, American College of Sports Medicine 2000). 
Medications Effect on heart rate during exercise (↑ = increase, 
↓ = decrease, ↔ = no effect) 
atropine ↑ 
agents blocking β-adrenergic receptors ↓*† 
nitrates ↑ or ↔ 
calcium channel blockers 
              dihydropyridine agents 
              diltiazem, verapamil  
 
↑ 
↓ or ↔ 
digitalis ↓‡ 
hydralazine, minoxidil ↑ or ↔ 
centrally acting antihypertensives (clonidine, 
methyldopa, moxonidine) 
↔ or ↓ 
 
antiarrhytmic agents 
               quinidine, disopyramide 
               propafenone  
               amiodarone 
 
↑ or ↔ 
↔ or ↓ 
↓ 
bronchodilatators 
               sympathomometic 
               anticholinergic 
               methylxanthines  
 
↑ or ↔ 
↑ or ↔ 
↑ or ↔ 
psychotropic medications 
               antidepressants 
               major tranquilizers  
 
↑ or ↔ 
↑ or ↔ 
cold medications with sympathomimetic agents ↑ or ↔ 
thyroid medications ↑ 
anorexiants / diet pills  ↑ or ↔ 
 
* β-blockers with intrinsic sympathomimetic activity have a reduced effect. 
† The effect increases with a relative intensity of exercise (Robinson et al. 1966, Ekblom et al. 1972, 
Hespel et al. 1986). 
‡ Heart rate decreases in patients with atrial fibrillation and possibly congestive heart failure but heart 
rate is not significantly altered in patients with sinus rhythm. 
 
 
Arterial oxygen content. A reduced arterial oxygen content in anemia or after 
haemoglobin blocked by carbon monoxide (as acutely after smoking) results in a higher 
HR at a fixed submaximal workload (Ekblom and Huot 1972, Wilkoff and Miller 1992, 
Higgins and Higgins 2007). Parenthetically, also smokeless tobacco increases HR at 
submaximal work (Van Duser and Raven 1992, Wilmore and Costill 2004). The increased 
blood haemoglobin concentration lowers HR at a given submaximal workload (Robertson 
et al. 1982, McArdle et al. 2001) but does not affect on maximal HR (Ekblom et al. 1976, 
Robertson et al. 1982). Long-term smokers seem to have a lower HR at a given 
submaximal workload (Gordon et al. 1987, Lauer et al. 1997, Srivastava et al. 2000) but 
unaltered (Blackburn et al. 1960, Ekelund et al. 1988, Slattery and Jacobs 1988) and higher 
(Chevalier et al. 1963) HR values have been reported as well. Long-term smokers have 
been reported to have a lower maximal HR (McHenry et al. 1977, Sandvik et al. 1995, 
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Lauer et al. 1997). Thyroid gland function. Hyperthyroid patients may have a high HR at 
a fixed submaximal workload (Wasserman et al. 1999, Higgins and Higgins 2007), 
whereas hypothyroid patients may have an opposite finding (Gentlesk et al. 2004). 
 
Circadian rhythm and seasons. HR display a circadian rhythm so that HR at a fixed 
submaximal workload is slightly higher at early afternoon (a peak around 13.30) compared 
with morning or late afternoon (Voigt et al. 1967, Reilly and Brooks 1990). On maximal 
HR the effect of circadian rhythm is negligible (Reilly and Brooks 1990). HR at a fixed 
submaximal workload has been shown to be lower in the summer than in other seasons 
(Sidney et al. 1992). Eating and sleeping before the test. HR at a fixed submaximal 
workload is increased for an hour or more after a heavy meal (Lange Andersen et al. 1971, 
Wilmore and Costill 2004). An abnormally short sleep the night before exercise may raise 
HR at a fixed submaximal workload (Wilmore and Costill 2004).   
 
Genetics. The workload which a person can attain at a submaximal HR of 150 beats/min is 
characterized by a significant familial resemblance, but the heritability as a percent of the 
age and gender-adjusted phenotypic variance is only <10% (Bouchard et al. 1984, Perusse 
et al. 1987, Perusse et al. 1988). The genetic effect on maximal HR has been shown to be 
significant in one study with brothers and twins (Bouchard et al. 1986) but not in another 
study (Fagard et al. 1987). Familial data has indicated that maximal HR may be 
characterized by a maternal effect (Lesage et al. 1985).  
 
2.9. HEART RATE RESPONSE TO SUBMAXIMAL EXERCISE AND 
PROGNOSIS  
 
During the last two decades, the novel exercise test derived HR variables like chronotropic 
incompetence and HR recovery have excited widely as prognostic markers of mortality and 
cardiac events both in asymptomatic persons and in patients with CVD (Ellestad 1996, 
Ashley et al. 2000a, Lauer 2001a, Lauer 2001b, Lauer 2001c, Gibbons et al. 2002a, Lauer 
2002a, Lauer 2002b, Lauer and Froelicher 2002, Chaitman 2003, Lauer 2003, Lauer 2004, 
Kaplan et al. 2005, Lauer et al. 2005, De Sutter et al. 2006, Freeman et al. 2006, Kligfield 
and Lauer 2006, Routledge and Townend 2006, Chaitman 2007). HR recovery is outside 
the scope of the present review, and therefore only HR variables measured during exercise 
test are discussed.  
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2.9.1 Submaximal heart rate and cardiovascular disease events in asymptomatic 
persons 
Seven reports (Hinkle et al. 1972, Wilhelmsen et al. 1976, Wilhelmsen et al. 1981, 
Sobolski et al. 1987, Ekelund et al. 1988, Slattery and Jacobs 1988, Pardaens et al. 1996) 
from six separate follow-up studies have examined the relationship between submaximal 
HR and future CVD events in asymptomatic persons as summarized in Table 2. Six papers 
measured the HR at a fixed submaximal workload (Hinkle et al. 1972, Wilhelmsen et al. 
1976, Wilhelmsen et al. 1981, Ekelund et al. 1988, Slattery and Jacobs 1988, Pardaens et 
al. 1996) and one paper (Sobolski et al. 1987) measured the workload which a person can 
attain at a fixed submaximal HR of 150 beats/min as the variable to quantify submaximal 
HR-work rate relationship. In two of the seven reports a high submaximal HR was found to 
be an independent predictor of a future CVD death (Ekelund et al. 1988, Slattery and 
Jacobs 1988). In one of the five papers which did not find an association survival analysis 
was not performed, the medications influencing HR were not explicitly reported, and the 
study sample included both healthy men and men with clinical evidence of definite or 
probable CHD (21.9% of the total sample) (Hinkle et al. 1972). Additionally, a prevalent 
CHD was not controlled for in the analysis (Hinkle et al. 1972). Two separate reports from 
one study (Wilhelmsen et al. 1976, Wilhelmsen et al. 1981) did not find an association 
either, but in both reports neither survival analysis was performed nor were the 
medications influencing HR reported. In the fourth paper with negative finding (Sobolski 
et al. 1987), the workload achieved at HR of 150 beats/min did not predict future CHD 
events as such, but after adjustment for body weight it was a strong independent predictor. 
In the fifth report with negative finding all subjects were hypertensive asymptomatic 
persons who were referred for the further investigation of hypertension (Pardaens et al. 
1996). Additionally, from the results of the study by Lauer et al (Lauer et al. 1996), it can 
be deduced that a high HR at a fixed submaximal workload did not predict CHD events, 
although the researchers did not directly examined that particular variable in their data.  
     
Table 2. The summary of the follow-up studies examining the relationship between submaximal heart rate and future cardiovascular disease 
events in asymptomatic persons*  
Study Total number 
of subjects  
Women 
(%) 
Age at 
baseline 
(years, 
range or 
mean± 
SD) 
Exclusion criteria Length of the 
follow-up 
(years, 
average/median 
if reported) 
Total 
number 
of events 
Use of 
medications 
affecting HR 
The variable 
to quantify 
submaximal 
HR-work 
rate 
relationship 
Main result 
Hinkle et al 
1972 (Hinkle et 
al. 1972) 
301 telephone 
company 
workers 
0% 55-60 not reported 7 26 CHD 
related 
deaths 
yes HR at 
submaximal 
workload in 
step test 
submaximal 
HR was not 
associated with 
the risk of 
CHD death   
Gothenburg 
Study 1976 
(Wilhelmsen et 
al. 1976)  
730 men 
living in 
Gothenburg 
and born in 
1913  
0% 54 locomotor 
disturbances, 
recent MI, 
unwillingness to 
cooperate 
8 30 
nonfatal 
AMIs, 19 
CHD 
related 
deaths 
not reported HR at 98 W in 
cycle 
ergometer test 
127 bpm in 
men having a 
CHD event vs. 
126 bpm in 
others (p=ns 
for difference) 
Gothenburg 
Study 1981  
(Wilhelmsen et 
al. 1981)  
730 men 
living in 
Gothenburg 
and born in 
1913  
0% 54 locomotor 
disturbances, 
recent MI, 
unwillingness to 
cooperate 
9 55 
nonfatal 
or fatal 
CHD 
events 
not reported HR at 98 W in 
cycle 
ergometer test 
“those who had 
a CHD event 
had the same 
submaximal 
HR as the 
others”  
Belgian 
Physical 
Fitness Study 
1987  
(Sobolski et al. 
1987)  
 
 
 
 
 
1476 factory 
workers 
0% 40-55 self-reported 
angina pectoris, an 
abnormal resting 
ECG, use of β-
blockers 
5 19 CHD 
events 
(sudden 
death or 
fatal or 
nonfatal 
AMI) 
β-blocker users 
excluded 
the workload 
attained at a 
HR of 150 
bpm (PWC150) 
the relationship 
between 
quartiles of 
PWC150 and 
incidence of 
CHD events 
not significant 
          
     
Table 2.  Continued         
Study Total number 
of subjects  
Women 
(%) 
Age at 
baseline 
(years, 
range or 
mean± 
SD) 
Exclusion criteria Length of the 
follow-up 
(years, 
average/median 
if reported) 
Total 
number 
of events 
Use of 
medications 
affecting HR 
The variable 
to quantify 
submaximal 
HR-work 
rate 
relationship 
Main result 
Lipid Research 
Clinics 
Mortality 
Follow-up 
Study 1988 
(Ekelund et al. 
1988)  
3106 men, 
most of them 
having 
hyperlipidemia  
0% 30-69 medication 
affecting HR,  
antihypertensive 
medication, signs 
of possible CVD  
8.5 (average) 45 CVD 
related 
deaths 
users excluded HR at stage 2 
in treadmill 
test (modified 
Bruce 
protocol) 
RR of CVD 
and CHD 
related death 
2.7 (95% CI 
1.4-5.1) and 
3.2 (1.5-6.7) 
with an 
increment of 
35 bpm   
US Railroad 
Study 1988 
(Slattery and 
Jacobs 1988)  
2431 railroad 
workers 
0% 22-79 pre-existing CVD 
as defined by 
standardized 
assessment 
20.0 (average) 258 CHD 
related 
deaths 
not reported HR at 
submaximal 
workload in 
treadmill test  
RR of CHD 
related death 
1.2 (95% CI 
1.1-1.3) when 
HR >135 bpm 
vs. HR <115 
bpm 
Pardaens et al 
1996  
(Pardaens et al. 
1996) 
216 
asymptomatic 
persons 
referred for the 
investigation 
of 
hypertension 
33.8% 35±12 
(men), 
43±10 
(women) 
diabetes, evidence 
of ischemic or 
valvular heart 
disease, heart 
failure, 
claudication, renal 
insufficiency, 
pulmonary disease 
16.5 (median) 53 
nonfatal 
or fatal 
CVD 
events 
antihypertensive 
medication 
stopped for at 
least 2 weeks 
HR at 50 W in 
cycle 
ergometer test 
submaximal 
HR was not 
associated with 
the risk of 
CVD event  
either in men 
or in women 
 
* For the first four studies the main result is from unadjusted analysis whereas for the next three studies the main results are from multivariable analyses. SD, standard 
deviation; HR, heart rate; CHD, coronary heart disease; MI, myocardial infarction; AMI, acute myocardial infarction; W, Watts; bpm, beats/minute; ns, not 
significant; ECG, electrocardiogram; CVD, cardiovascular disease; RR, relative risk, CI, confidence interval. 
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Only one of the seven reports involved also women (Pardaens et al. 1996) and the negative 
finding was observed similarly in both gender. The length of the follow-up was addressed 
in one study (Slattery and Jacobs 1988) in which the exercise test was performed twice 
enabling the researchers to calculate the results with two separate follow-up periods of 
about 15 and 20 years. They showed that the predictive value of HR at a fixed submaximal 
workload for future CHD death improved then a shorter follow-up after the second 
exercise test was used, even if the number of events decreased from 258 to 147 (Slattery 
and Jacobs 1988). 
 
In two studies which found a high submaximal HR to be an independent predictor of future 
CVD death (Ekelund et al. 1988, Slattery and Jacobs 1988) a high submaximal HR was 
interpreted as a marker of a low cardiorespiratory fitness and therefore the association with 
CVD death was explained by this mechanism. The conjecture that the association is 
mediated by a low cardiorespiratory fitness is supported by the facts that HR at a fixed 
workload is inversely related to a maximal cardiorespiratory performance of a subject 
(Christensen 1931b, Tavel 2001, Higgins and Higgins 2007) and a low cardiorespiratory 
fitness is a major risk factor for future CVD event in asymptomatic persons (Mark and 
Lauer 2003, Lauer et al. 2005, Froelicher and Myers 2006). 
 
Indirect support for the association between a high submaximal HR and increased risk of 
future CVD events is found from four follow-up studies (Peters et al. 1983, Lie et al. 1985, 
Arraiz et al. 1992, Hein et al. 1992). In these studies the actual submaximal HR was not 
reported but either age-adjusted value was used for analyses, or submaximal HR was 
utilized for indirect estimating of cardiorespiratory fitness (Peters et al. 1983, Lie et al. 
1985, Arraiz et al. 1992, Hein et al. 1992). In all four studies (Peters et al. 1983, Lie et al. 
1985, Arraiz et al. 1992, Hein et al. 1992) an estimated low cardiorespiratory fitness was 
associated with an increased risk of CVD events. Because a low cardiorespiratory fitness 
estimated from an indirect test is based on a high submaximal HR (Lange Andersen et al. 
1971, McArdle et al. 2001, Åstrand et al. 2003), it is presumable that persons with an 
increased risk of CVD death in all four studies had a high HR at a fixed submaximal 
workload as well.   
 
A high HR at a fixed submaximal workload, or a low workload attained at a fixed 
submaximal HR, has been shown to be associated with risk factors for CVD, such as a low 
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serum high-density lipoprotein (HDL) cholesterol level (Peters et al. 1983, Ekelund et al. 
1988); a high serum total cholesterol (Peters et al. 1983, Filipovsky et al. 1992), low-
density lipoprotein (LDL) cholesterol (Ekelund et al. 1988) and triglyceride level (Ekelund 
et al. 1988); a low HDL/total cholesterol ratio (Peters et al. 1983); a low level of self 
reported physical activity (Wilhelmsen et al. 1976, Ekelund et al. 1988, Sidney et al. 
1992); a high resting systolic (Jonsson and Astrand 1979, Slattery and Jacobs 1988, 
Filipovsky et al. 1992,) and diastolic BP (Ekelund et al. 1988); a diagnosed hypertension 
(Bruce et al. 1974); as well as overweight (Buskirk et al. 1955, Dempsey et al. 1966, 
Sidney et al. 1992) in asymptomatic persons. On the other hand, smokers seem to have a 
lower HR at a given submaximal workload than nonsmokers (Gordon et al. 1987, Lauer et 
al. 1997, Srivastava et al. 2000). Also left ventricular hypertrophy assessed from ECG has 
been reported to be related with a lower HR at a given submaximal workload (Filipovsky 
et al. 1992). Total cholesterol and BP level were controlled for, however, in two studies 
(Ekelund et al. 1988, Slattery and Jacobs 1988) which found the association between 
submaximal HR and the increased risk of CVD death. Slattery and Jacobs (Slattery and 
Jacobs 1988) performed stepwise analysis which revealed that the predictive value of the 
HR at a fixed submaximal workload was attenuated most by resting systolic BP, but the 
association remained statistically significant. Furthermore, the associations of submaximal 
HR with total (Lopez et al. 1974, Montoye et al. 1976) and HDL cholesterol (Haskell et al. 
1980, Gordon et al. 1987, Ekelund et al. 1988) level; overweight (Gordon et al. 1987, 
Ekelund et al. 1988, Filipovsky et al. 1992); a low level of self reported physical activity 
(Filipovsky et al. 1992); as well as smoking (Blackburn et al. 1960, Ekelund et al. 1988, 
Slattery and Jacobs 1988) have not been observed consistently.  
 
2.9.2 Submaximal heart rate and cardiovascular disease events in patients with 
known or suspected coronary heart disease 
The relationship between HR at a fixed submaximal workload and mortality as well as 
CVD events in patients with known or suspected CHD has not been investigated in 
previous studies. However, indirect evidence is available from two studies (Falcone et al. 
2005, Leeper et al. 2007) which have measured the HR increment from rest to submaximal 
workload. Falcone et al (Falcone et al. 2005) followed 458 men with angiographically 
verified CHD for six years. They found that patients whose HR rose 12 beats/min or more 
from rest to one minute at workload of 25 Watts (W) at the beginning of exercise test had 
5.8 and 13.5 times higher risk of adverse cardiac event and cardiac death, respectively, 
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than patients with a milder HR increment (Falcone et al. 2005). Leeper et al (Leeper et al. 
2007), however, did not find any association between HR increment from rest to a fixed 
submaximal workload and all-cause or CVD mortality after following 1959 patients (5% 
women) referred for exercise testing for 5.4 years. Falcone et al (Falcone et al. 2005) 
reasoned the rapid HR increment resulting from a premature vagal withdrawal which in 
turn might be a marker of sympathetic overactivity or a reduced vagal activity, the known 
risk factors for death or cardiac event in CHD patients especially after myocardial 
infarction (Kleiger et al. 1987, Makikallio et al. 2005, Kiviniemi et al. 2007). The 
explanation offered by Falcone et al (Falcone et al. 2005) is not supported by the findings 
from a previous study in which HR increase from rest to one minute was lower in 12 CHD 
or cardiomyopathy patients with depressed baroreflex sensitivity (a marker of vagal 
activity) compared with patients with a normal baroreflex sensitivity (Fukuma et al. 2004). 
Accordingly, Leeper et al (Leeper et al. 2007) argued that the rapid HR increment at the 
beginning of exercise test reflects a high, instead of low, vagal activity and they further 
suggested the early acceleration of HR in the study by Falcone et al (Falcone et al. 2005) to 
be a marker of a low cardiorespiratory fitness, a known risk factor for death or cardiac 
event in persons with known or suspected CHD (Morris et al. 1991, Froelicher and Myers 
2006). 
 
Some authors have suggested that a high HR at a fixed submaximal HR may result from an 
inadequate stroke volume increase accompanying an impaired left ventricular function 
originating from either myocardial ischemia (Hultgren et al. 1986, Wasserman 1997, 
Myers and Madhavan 2001) or from left ventricular dysfunction not directly related to 
ischemia (Weber et al. 1982). According to this view, a high submaximal HR is a 
baroreceptor-mediated compensatory mechanism as an attempt to preserve an adequate 
cardiac output rise during exercise in the face of an impaired left ventricular function 
(Wasserman 1997, Wasserman et al. 1999). Hence, the association of a high submaximal 
HR with an increased risk of death could be explained by an impaired left ventricular 
function, a known risk factor for death in CHD patients (Froelicher and Myers 2006). In 
accordance with this are the findings from two previous studies in dogs (Billman et al. 
1985, Billman and Hoskins 1989). The rise of HR at the early phase of an exercise stress 
was steeper in dogs with a healed myocardial infarction that were susceptible to ventricular 
fibrillation after experimentally induced coronary occlusion as compared with dogs that 
were resistant to ventricular fibrillation. The susceptibility to ventricular fibrillation was 
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associated with a greater degree of left ventricular dysfunction which was possibly due to 
significantly higher proportion of transmural infarctions in susceptible dogs (Billman et al. 
1985). 
 
2.10 SUMMARY 
 
HR response to exercise, although simple to assess, reflects a complex, integrated 
physiologic response in which autonomic tone, central and peripheral reflexes, hormonal 
influences, and factors intrinsic to the heart are all important (Hammond and Froelicher 
1985, Hainsworth 1995, Iellamo 2001). During the last two decades, the exercise test 
derived HR variables have excited widely as prognostic markers of mortality and cardiac 
events both in asymptomatic persons and in CVD patients (Ellestad 1996, Ashley et al. 
2000a, Lauer 2001a, Lauer 2001b, Lauer 2001c, Gibbons et al. 2002a, Lauer 2002a, Lauer 
2002b, Lauer and Froelicher 2002, Chaitman 2003, Lauer 2003, Lauer 2004, Kaplan et al. 
2005, Lauer et al. 2005, De Sutter et al. 2006, Freeman et al. 2006, Kligfield and Lauer 
2006, Routledge and Townend 2006, Chaitman 2007). The results of the properly 
controlled studies (Ekelund et al. 1988, Slattery and Jacobs 1988, Sandvik et al. 1995, 
Lauer et al. 1996, Cheng et al. 2002, Mora et al. 2003, Balady et al. 2004, Erikssen et al. 
2004, Jouven et al. 2005) suggest a possible bimodal relationship of HR to prognosis in 
which both high HR at low workload and inappropriately low HR at maximal or near 
maximal workload (i.e. chronotropic incompetence) are associated with adverse prognosis 
(Ramamurthy et al. 1999). Indeed, in the Lipid Research Clinics Mortality Follow-up 
Study both a high HR at a fixed submaximal workload (Ekelund et al. 1988) and an 
inability to increase HR normally when approaching maximal wok capacity (chronotropic 
incompetence) (Srivastava et al. 2000) were associated with an adverse prognosis in two 
papers from the same study sample.  
 
A high HR at a fixed submaximal workload has consistently been interpreted as a marker 
of a low cardiorespiratory fitness, and therefore the association with CVD death has been 
explained by this mechanism (Ekelund et al. 1988, Slattery and Jacobs 1988, Leeper et al. 
2007,). Interestingly, however, there are no published population-based follow-up studies 
exploring this hypothesis in which HR at a fixed submaximal workload and 
cardiorespiratory fitness would have been entered into the same regression model 
predicting future CVD events. The mechanism mediating the association between 
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chronotropic incompetence and an increased risk of CVD event is not known although 
several possibilities has been presented (Wilkoff and Miller 1992, Sandvik et al. 1995, 
Camm and Fei 1996; Ellestad 1996, Kohl et al. 1996, Lauer et al. 1996, Lauer 2001; Curtis 
and O'Keefe 2002, Gentlesk et al. 2004, Jouven et al. 2005, Kaplan et al. 2005, De Sutter 
et al. 2006, Freeman et al. 2006, Routledge and Townend 2006).  
 
The hypothetical graph based on the results from previous studies (Billman et al. 1985, 
Ekelund et al. 1988, Slattery and Jacobs 1988, Billman and Hoskins 1989, Sandvik et al. 
1995, Lauer et al. 1996, Cheng et al. 2002, Mora et al. 2003, Balady et al. 2004, Erikssen 
et al. 2004, Falcone et al. 2005, Jouven et al. 2005, Leeper et al. 2007) is shown in Figure 
2. In essence, it is the theory proposed by Ramamurthy et al (Ramamurthy et al. 1999) in a 
graph form. The hypothesis has a physiologically relevant basis, because HR increase from 
rest to maximal exercise is known to consist of two consecutive phases: the early rise up to 
a rate of 100 beats/min is controlled mainly by parasympathetic nervous system (Craig 
1952, Tulppo et al. 1996, Rohrer et al. 1998), whereas the increase from 100 beats/min to 
maximum is controlled mainly by sympathetic nervous system (Epstein et al. 1965, Brown 
et al. 1986, Hespel et al. 1986). In the current study the hypothesis presented in Figure 2 is 
further extended by suggesting that the predictive value of a high HR at a submaximal 
workload can be optimized if a submaximal HR response is quantified as a workload 
achieved at HR of 100 beats/minute (WL100). The HR of 100 beats/min is used, because it 
is the upper bound of the first, parasympathetically (Craig 1952, Tulppo et al. 1996, Rohrer 
et al. 1998) controlled phase of the total HR rise during exercise and it has been proposed 
that an exaggerated HR response particularly during this phase indicates an adverse 
prognosis (Billman et al. 1985, Billman and Hoskins 1989, Falcone et al. 2005). The 
prognostic value of the new HR-derived variable, WL100, has not been studied formerly.  
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heart 
rate 
workload
 
Figure 2. The hypothetical heart rate response to incremental exercise in subjects with an increased risk of 
future cardiovascular disease event (dashed line) and in normal subjects (continuous line) based on the data 
from the previous studies (Billman et al. 1985, Ekelund et al. 1988, Slattery and Jacobs 1988, Billman and 
Hoskins 1989, Sandvik et al. 1995, Lauer et al. 1996, Cheng et al. 2002, Mora et al. 2003, Balady et al. 2004, 
Erikssen et al. 2004, Falcone et al. 2005, Jouven et al. 2005, Leeper et al. 2007). 
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3 MAIN HYPOTHESIS AND AIMS OF THE STUDY 
 
The main hypothesis of the current thesis is that a low workload achieved at HR of 100 
beats/min (WL100) is associated with adverse prognosis. Accordingly, the aims of the study 
were:  
 
a) to investigate the association between WL100 and the risk of CVD death in middle-aged 
men free of CHD. 
 
b) to study  the association between WL100 and the risk of death in middle-aged men with 
known or suspected CHD and its prognostic value beyond other HR-derived and exercise 
test variables.  
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4 METHODS 
 
4.1 STUDY POPULATION 
 
The subjects were participants of the Kuopio Ischaemic Heart Disease Risk Factor Study 
(KIHD), a collaborative research project between the Kuopio Research Institute of 
Exercise Medicine and the Research Institute of Public Health, the University of Kuopio. 
The KIHD is an ongoing population study designed to investigate risk factors for CVD and 
related outcomes (Salonen 1988). The study involves men from East Finland, an area 
known for its high prevalence and incidence of CVD (Keys et al. 1984, Salonen 1988). The 
study protocol was approved by the Research Ethics Committee of the University of 
Kuopio and complies with the Declaration of Helsinki. Each participant gave a written 
informed consent. The subjects are a representative age-stratified, age-balanced 
population-based random sample of men who lived in the town of Kuopio or neighbouring 
rural communities. Of the 3235 eligible men, 2682 (82.9% of those alive) were recruited in 
two cohorts. The first cohort consisted of 1166 54-year-old men (83.3% of those alive) and 
was enrolled in the study between March 1984 and August 1986, the second cohort was an 
age-stratified sample of 1516 42-, 48-, 54-, and 60-year-old men (82.6% of those alive) and 
was enrolled between August 1986 and December 1989.  
 
Complete data on exercise test variables were available for 2240 men. WL100 could not be 
recorded or interpolated for 113 men because they had either a resting HR higher than 100 
beats/min or no HR values above 100 beats/min during an exercise test. Data on the 
prevalence of CHD, ischemic changes in ECG during an exercise test, or the use HR-
lowering medication (beta-blockers, digoxin, clonidin, methyldopa) were missing for 299 
men. Of 1828 men with complete data, 149 men without CHD at baseline but using HR-
lowering medication were excluded. After these exclusions, the final study sample 
included 1679 men who were divided into two groups: 1314 men without CHD at baseline, 
and 365 men with known or suspected CHD at baseline. Known or suspected CHD was 
defined as either a history of myocardial infarction (90 men in the final study sample) or 
angina pectoris diagnosed by a doctor (226 men), angina pectoris on effort based on the 
London School of Hygiene Cardiovascular Questionnaire (Rose et al. 1982) (284 men), or 
the use of nitroglycerine for chest pain at least once a week (61 men).  
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4.2 EXAMINATION PROTOCOL  
 
Examinations at baseline were carried out over two days, one week apart, and consisted of 
a wide variety of biochemical, physiological, anthropometric, and psychosocial measures 
(Salonen 1988). Invitations to attend the first study visit and written instructions to 
complete a detailed self-administered questionnaire were mailed four weeks in advance. At 
the first visit, a trained interviewer checked the completed questionnaire and a nurse 
measured body height and weight and blood pressure. The subjects underwent a medical 
examination, during which information about medical history and use of medications 
obtained from the self-administered questionnaire was checked. At the first visit, a 
maximal, symptom limited cycle ergometer test was performed (Lakka et al. 1994, Lakka 
et al. 2001, Laukkanen et al. 2001, Laukkanen et al. 2004, Laukkanen et al. 2006a; 
Laukkanen et al. 2006b).  
 
At the second visit after seven days the blood specimens were taken for laboratory 
determinations between 8 and 10 o’clock in the morning. For these blood samples, the 
subjects were instructed to fast and to abstain from smoking for 12 hours, to abstain from 
drinking alcohol for 3 days, and to abstain from using analgesics for 7 days. After the 
subjects had rested in a supine position for 30 minutes, blood was drawn with Terumo 
Venoject vacuum tubes (Tokyo, Japan). No tourniquet was used.  
 
4.3 EXERCISE TESTING 
 
HR response, cardiorespiratory fitness, exercise induced myocardial ischemia and BP 
response were assessed using a maximal, symptom limited cycle ergometer exercise test on 
an electrically braked cycle ergometer. For men examined before June 1986, the testing 
protocol comprised of a three-minute warm-up at 50 W followed by a step-by-step increase 
in the workload by 20 W per minute (early protocol) (Tunturi EL 400, Turku, Finland). 
The remaining men were tested with a linear increase in the workload by 20 W per minute 
(later protocol) (Medical Fitness Equipment 400L, Mearn, Netherlands). For safety reasons 
and to obtain reliable information, the test was supervised by an experienced physician 
with the assistance of a trained nurse.  
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4.3.1 Assessment of heart rate response to exercise 
HR was recorded from ECG at rest, at the end of each 60-second interval during the 
exercise test, and at peak exercise. HR represents a prevailing value at that time point 
obtained from sample interval of approximately 3 seconds and measured digitally by 
electrocardiograph. Resting HR was expressed as the lowest HR value, whether measured 
in lying position before the test or while sitting on bicycle before the test. WL100 was 
recorded directly at HR of 100 beats/min or interpolated linearly as a function of HR by 
using resting HR and the nearest HR value above 100 beats/min. Chronotropic index at HR 
of 100 beats/min was calculated as ((100 – resting HR) / (maximal HR – resting HR)) / 
(workload at HR 100 beats/min / maximal workload). Chronotropic index at HR of 100 
beats/min quantitatively expresses how steep the early rise of HR from rest to 100 
beats/min is in relation to the overall steepness of HR rise during the exercise test. A value 
of roughly 1 means that the steepness of the early HR rise from rest to 100 beats/min is 
about the same as the HR rise from that time point to maximum. Correspondingly, a value 
larger than 1 means that the early HR rise is steeper than the HR rise from that time point 
to maximum. HR at 40, 60, 80, and 100 % of maximal workload was interpolated linearly 
as a function of HR by using the nearest HR values below and above the time point 
respectively. HR increase from rest to 50 W as well as HR increase from rest to 33% of 
maximal workload were calculated as the difference between HR at corresponding time 
point and resting HR (Falcone et al. 2005, Leeper et al. 2007). Heart rate reserve was 
calculated as maximal HR minus resting HR. 
 
4.3.2 Assessment of cardiorespiratory fitness and exercise electrocardiography  
VO2max and exercise test duration were used as measures of cardiorespiratory fitness. 
Respiratory gas exchange was measured by the mixing chamber method with the use of a 
Mijnhardt Oxycon 4 analyzer (Gebr. Mijnhardt B.V., Netherlands) for men examined 
before June 1986 and by the breath-by-breath method with the use of a MGC 2001 
analyzer (Medical Graphics Corp., St. Paul, Minnesota, USA) for the remaining men. 
VO2max was defined as the highest value for VO2 recorded during the 30-second interval. 
 
ECG was recorded continuously with the Kone 620 electrocardiograph (Kone, Turku, 
Finland). The Mason-Likar lead system including V1, V5 and aVF lead connections was 
used (Mason and Likar 1966). ECG was printed every 60 seconds intervals during 
exercise. Exercise ECGs were coded manually by one cardiologist. The criteria for 
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ischemia in ECG during exercise was horizontal or downsloping ST depression with 0.5 or 
more mm at 80 milliseconds after J point in men without CHD at baseline, and horizontal 
or downsloping ST depression with 1.0 or more mm in men with known or suspected CHD 
at baseline.  
 
4.4 BIOCHEMICAL ANALYSES   
 
Fasting blood glucose was measured using the glucose dehydrogenase method (Merck, 
Darmstadt, Germany) after proteins had been precipitated with trichloroacetic acid. The 
main lipoprotein fractions (LDL, HDL) were separated from fresh serum samples using 
precipitation and ultracentrifugation (Salonen et al. 1991). The cholesterol contents of 
lipoprotein fractions were measured enzymatically (Boehringer Mannheim, Mannheim, 
Germany) on the day after the ultracentrifugal spin. Blood haemoglobin was determined 
photometrically (Gilford Stasar III, Gilford Instrument Laboratories Inc., Oberlin, Ohio, 
USA) using the cyanmethaemoglobin method (Fairbanks 1976) within a few hours of 
blood sampling.  
 
4.5 RESTING BLOOD PRESSURE, BODY WEIGHT AND BODY MASS INDEX 
 
Resting BP was measured between 8 and 10 o’clock in the morning by two trained nurses, 
one during 1984 to 1985 and another during 1986 to 1989, with a random-zero mercury 
sphyghomanometer (Hawksley, Lancing, UK). The measurement protocol included, after 
supine rest of five minutes, three measurements in the supine, one in the standing and two 
in the sitting position with five minutes’ intervals. Blood pressure was read with an 
accuracy of two mmHg. The disappearance of sounds (Korotkoff’s fifth phase) was 
recorded as diastolic BP. In the present study the mean of all six measurements was used 
as systolic and diastolic BP. 
 
Body weight was measured using a balance scale. The subject wore light clothing and no 
shoes. BMI was computed by dividing body weight in kilograms by the square of body 
height in meters. 
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4.6 SMOKING AND ALCOHOL CONSUMPTION 
 
The current number of cigarette, cigars, and pipefuls of tobacco smoked daily and the 
duration of regular smoking in years were recorded using a self-administered 
questionnaire. Years smoked were defined as the sum of the years of smoking, regardless 
of when it had started, whether the subject had currently stopped smoking, or whether it 
had occurred continuously or during several periods. The lifelong exposure to smoking 
(“cigarette years”) was estimated as the product of years smoked and the number of 
tobacco products smoked daily at the time of the examination, or for ex-smokers, at the 
time when they had smoked last time. Alcohol consumption was assessed with a structured 
quantity-frequency questionnaire using the Nordic Alcohol Consumption Inventory on 
drinking behaviour over the previous 12 months. The average weekly consumption of 
alcohol in pure ethanol (g/week) was calculated based on the known alcoholic content of 
each beverage type and the reported doses and frequencies of drinking sessions (Kauhanen 
et al. 1997). 
 
4.7 BASELINE DISEASES AND MEDICATIONS  
 
Medical history and the use of medications were assessed using a self-administered 
questionnaire. A physician reinterviewed the subjects regarding their medical history and 
the use of medications during a medical examination. A prevalent CVD was defined as a 
history of CHD, cardiac insufficiency, cardiomyopathy, arrhytmias, stroke or claudication. 
Diabetes was defined as fasting blood glucose ≥6.7 mmol/l (World Health Organization 
1985) or a clinical diagnosis of diabetes with either dietary, oral, or insulin treatment.  
 
4.8 COLLECTION AND CLASSIFICATION OF DEATHS DURING THE 
FOLLOW-UP 
 
All deaths were ascertained by computer linkage to the Finnish National Death Registry 
using the Finnish social security number. There were no losses to follow-up. All deaths 
that occurred between study enrollment (from March 20, 1984 to December 5, 1989) and 
December 31, 1998 were included. Deaths from CVD and CHD were coded according to 
the Ninth International Classification of Diseases (ICD) codes (390-459 and 410-414, 
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respectively) (World Health Organization 1977) or the Tenth ICD codes (I00-I99 and I20-
I25, respectively) (World Health Organization 1992).  
 
4.9 STATISTICAL METHODS 
 
Statistical analyses were performed by using SPSS 11.5 for Windows (SPSS, Inc., 
Chicago, Illinois). Descriptive data are presented as mean and standard deviations (SDs), 
or medians and ranges, respectively, for continuous data and percentages for categorical 
data. Differences in baseline characteristics were examined using age-adjusted linear and 
logistic regression analyses, and exact Mann-Whitney U-test was used with age. A 
multiple stepwise linear regression analysis including resting HR, chronotropic index at 
HR of 100 beats/min, maximal HR, and VO2max was used to investigate the determinants of 
WL100. 
 
The association of HR-derived and other exercise test variables with the risk of outcomes 
were analyzed using Cox proportional hazards’ models (Cox 1972). The Cox model 
assumes that the hazard which equals the instantaneous death rate is given by the formula: 
hi(t)=h(t)Ci, where Ci=exp(B1X1i+ B2X2i+…+ BpXpi) (Shetler et al. 2001, Froelicher et al. 
2002, Froelicher et al. 2003). The model assumes that the hazard (h) of death for patient I 
at time t (h1(t)) equals the hazard of death for an “average patient” at the same time (h(t)) 
multiplied by the factor (Ci) that is the function of the prognostic profile of patient I; this is 
a proportional hazards assumption that gives a model its name (Shetler et al. 2001, 
Froelicher et al. 2002, Froelicher et al. 2003). The proportional coefficient for patient i (Ci) 
is, in turn, a function of the values for that patient of a set of prognostic factors (X1i,…, 
Xpi), multiplied by a corresponding set of regression coefficients (B1,…, Bp) that measure 
the strength of the association between the prognostic factor and outcome of large number 
of subjects) (Shetler et al. 2001, Froelicher et al. 2002, Froelicher et al. 2003). Relative 
risks (RRs), adjusted for risk factors, were estimated as antilogarithms of coefficients from 
multivariable models. Their confidence intervals (CIs) were estimated under the 
assumption of asymptomatic normality of the estimates. The proportional-hazards 
assumption was verified by inspection of the plots of Schoenfeld residuals for covariates 
(Grambsch and Therneau 1994). Linearity of associations was assessed with the 
Martingale residuals (Therneau et al. 1990). No violations were observed.  
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Age, examination year, exercise test protocol (and the use of HR-lowering medication in 
men with known or suspected CHD at baseline) were forced into the Cox models, and rest 
of the variables were chosen by backward stepwise selection (p-value >0.1 for removal) 
from conventional risk factors. In men without CHD at baseline these variables included 
alcohol consumption, BMI, cigarette smoking, CVD history, diabetes, myocardial ischemia 
during exercise test, serum LDL and HDL cholesterol, and systolic and diastolic BP at rest. 
In men with known or suspected CHD at baseline the corresponding covariates included 
alcohol consumption, BMI, cigarette smoking, cardiac insufficiency, history of myocardial 
infarction, diabetes, myocardial ischemia during exercise test, serum LDL and HDL 
cholesterol, and systolic and diastolic BP at rest.   
 
In further analyses, the sample was restricted to subjects who remained free of events 
during the first 2 years of follow-up. To detect the best cut-off point for a variable, the 
dichotomization cut-off point that maximized the log-rank test statistics was sought, and 
the predictive power of this categorized variable was tested by using Cox models. The 
additional predictive value brought by WL100 beyond other HR-derived and exercise test 
variables was explored by entering WL100 into a Cox model that included age, examination 
year, exercise test protocol, the use of HR-lowering medication in men with known or 
suspected CHD at baseline, conventional risk factors chosen by stepwise selection, and the 
HR and exercise test variables in turns.  
 
In men with known or suspected CHD at baseline, the association of WL100 with mortality 
was examined separately in men who did not use HR-lowering medication and in men who 
used such medication. Difference in WL100 between two different testing protocols was 
tested using linear regression analysis after adjustment for age (and the use of HR-lowering 
medication in men with known or suspected CHD at baseline). To address specifically the 
effect of two different exercise test protocols the stepwise selection was performed 
separately in corresponding subgroups. In supplementary analyses with men without CHD 
at baseline, the sample was restricted to subjects who had none of the following: history of 
cancer, history of CVD, history of chronic obstructive pulmonary disease, bronchial 
asthma or pulmonary tuberculosis, or dizziness, dyspnea, chest pain, arrhythmia, ischemic 
ECG changes or change in BP as a cause of discontinuation of a test. In the corresponding 
analysis with men with known or suspected CHD at baseline, the sample was restricted to 
subjects who had none of the following: history of cancer, history of cardiomyopathy, 
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stroke or claudication, history of chronic obstructive pulmonary disease, bronchial asthma 
or pulmonary tuberculosis, or dizziness, dyspnea, chest pain, symptoms of cardiac 
insufficiency, arrhythmia, ischemic ECG changes or change in BP as a cause of 
discontinuation of a test. 
 
All tests for statistical significance were two-sided. A value of p less than 0.05 was 
considered statistically significant.   
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5 RESULTS 
 
5.1 WORKLOAD AT HEART RATE OF 100 BEATS/MIN DURING EXERCISE 
TEST AND MORTALITY IN MEN WITHOUT CORONARY HEART DISEASE  
 
At baseline, the median (range) age of the men was 52 (42-61) years, and the mean (SD) 
WL100 was 63 (31) W (Table 3). Baseline characteristics according to halves of WL100 are 
shown in Table 1. Resting HR explained 39%, chronotropic index at HR of 100 beats/min 
21%, VO2max 5%, maximal HR 5%, and all these variables together 70% of the variance in 
WL100. Heart rate vs. workload for those who died during follow-up due to CVD and 
survivors is shown in Figure 3. 
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Figure 3. Heart rate (mean) as a function of workload in men who died during follow-up due to 
cardiovascular disease (n=51, dashed line) and survivors (n=1263, continuous line). Workload achieved at 
heart rate of 100 beats/min is indicated with vertical lines for each group. Standard deviations are not shown 
because the number of subjects in both groups gradually decreased along with increasing workload.  
 
Men with a low WL100 were over 2-times more likely to die of CVD and about 3-times 
more likely to die of CHD than those with a high WL100 (Table 3). CVD mortality 
increased by 72% (95% CI 27%-138%, p=0.001), CHD mortality by 96% (32%-186%,  
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Table 3. Baseline Characteristics in 1314 Men with No History of Coronary Heart Disease 
and Not Using Heart Rate Lowering Medication at Baseline   
Characteristics Mean (SD), median (range) or proportion p-value for 
difference between 
groups¶ 
 All men 
(n=1314) 
WL100 below 
median value 64 
Watts†† 
WL100 above 
median value 64 
Watts†† 
 
Number of CVD / 
CHD / all-cause 
deaths† 
51 / 35 / 133 37 / 26 / 73 14 / 9 / 60 0.002 / 0.006 / 0.25 
Age (years) 52 (42-61) 52 (42-61) 52 (42-61) 0.56 
Body mass index 
(kg/m2) 
26.5 (3.5) 26.6 (3.5) 26.4 (3.2) 0.25 
Cigarette smoking 
(cigarette-years)§ 
144 (299) 151 (319) 138 (277) 0.42 
Alcohol consumption 
(g/week) 
73 (110) 76 (119) 70 (101) 0.33 
Cardiovascular disease 
history (%)* 
14.5 13.8 15.1 0.50 
Diabetes (%)|| 3.7 4.7 2.6 0.04 
Serum HDL 
cholesterol (mmol/l) 
1.32 (0.29) 1.30 (0.28) 1.35 (0.30) 0.003 
Serum LDL cholesterol 
(mmol/l) 
3.98 (0.97) 4.02 (0.99) 3.95 (0.95) 0.18 
Diastolic blood 
pressure at rest 
(mmHg) 
88 (10) 90 (10) 86 (9) <0.001 
Systolic blood pressure 
at rest (mmHg) 
133 (15) 135 (16) 130 (14) <0.001 
Maximal oxygen 
uptake (ml/kg/min) 
33.2 (7.3) 31.9 (6.9) 34.5 (7.5) <0.001 
Myocardial ischemia 
during exercise test 
(%)** 
13.9 12.0 15.9 0.04 
Resting heart rate 
(beats/min) 
68 (10) 73 (10) 63 (8) <0.001 
Chronotropic index at 
heart rate of 100 
beats/min‡ 
1.13 (0.28) 1.28 (0.29) 0.98 (0.17) <0.001 
Maximal heart rate 
(beats/min) 
162 (17) 166 (16) 158 (17) <0.001 
Heart rate reserve 
(beats/min)# 
94 (19) 93 (19) 96 (19) 0.03 
Workload at heart rate 
of 100 beats/min 
(Watts) 
63 (31) 38 (17) 88 (19) <0.001 
 
* Cardiovascular diseases included arrhytmias, cardiomyopathy, claudication, heart failure, and stroke.  
† CVD, cardiovascular disease; CHD, coronary heart disease. 
‡ Chronotropic index at heart rate of 100 beats/min was calculated as ((100 – resting heart rate) / 
(maximal heart rate – resting heart rate)) / (workload at heart rate of 100 beats/min / maximal 
workload) (Salonen et al. 1991). 
§ Cigarette-years denotes the lifelong exposure to smoking which was estimated as the product of years 
smoked and the number of cigarettes smoked daily at the time of examination (19). 
|| Diabetes was defined as fasting glucose ≥6.7 mmol/l or use of medication for diabetes.  
¶ Difference in age was tested with Mann-Whitney U-test. Differences in cardiovascular disease 
history, diabetes, myocardial ischemia during exercise test, and number of deaths were tested with 
logistic-regression analysis and in rest of the variables with linear regression analysis after adjustment 
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Table 3. Continued 
for age. 
# Heart rate reserve was calculated as maximal heart rate – resting heart rate. 
** Myocardial ischemia during exercise test was defined as a horizontal or downsloping ST depression 
of >1.0 mm at 80 msec after the J-point. 
††        WL100, workload at heart rate of 100 beats/min. 
 
p=0.001), and all-cause mortality by 23% (2%-47%, p=0.03) with a decrement of 31 W (1 
SD) in WL100 adjusting for age, examination year, and exercise test protocol. After further 
adjustment for conventional risk factors, CVD mortality increased by 72% (95% CI 27%-
138% p=0.001) and CHD mortality by 89% (28%-178%, p=0.001) with a decrement of 31 
W in WL100, but no association was found between WL100 and all-cause mortality (Table 
4). Entering the whole set of covariates into the model weakened the independent 
predictive value of WL100 for CVD (p=0.006) and CHD death (p=0.001) marginally.  
 
To address specifically the late events, the analyses were restricted to 1303 subjects who 
had at least 2 years of event-free follow-up. The analyses included 47 CVD deaths and 33 
CHD deaths. The risk of CVD and CHD death increased by 67% (95% CI 20%-133%, 
p=0.002) and 96% (32%-194%, p=0.001) for a 1-SD (31 W) decrement in WL100, 
respectively. 
 
The best WL100 cut-off point for predicting CVD mortality was 50 W, and 497 men 
(37.8%) had WL100 <50 W. Altogether 32 (63% of total) CVD deaths and 24 (69%) CHD 
deaths were observed among men with WL100 <50 W. When WL100 was entered as a 
dichotomous variable with conventional risk factors into a backward stepwise Cox model, 
the strongest predictors of CVD death were smoking (p<0.001), WL100 <50 W (RR 3.2, 
95% CI 1.8-5.8, p<0.001), myocardial ischemia during exercise test (p<0.001), a high BMI 
(p=0.001), a high age (p=0.001), and CVD history (p=0.008). The strongest predictors of 
CHD death were myocardial ischemia during exercise test (p<0.001), smoking (p<0.001), 
WL100 <50 W (RR 3.9, 95% CI 1.9-8.2, p<0.001), a high BMI (p=0.01), a high age 
(p=0.03), and CVD history (p=0.05). The Kaplan-Meier curves for cumulative incidence of 
CVD and CHD deaths between men with WL100 <50 W and men with WL100 ≥50 W 
continued to diverge with extended time of follow-up as shown in Figure 4. 
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Table 4. The relative risk for cardiovascular disease, coronary heart disease, and all-cause 
death in 1314 men with no history of coronary heart disease at baseline* 
Risk factor Death due to cardio-
vascular disease 
Death due to coronary 
heart disease 
All-cause death 
 Relative risk  
(95% CI) 
p-value Relative risk  
(95% CI) 
p-value Relative risk  
(95% CI) 
p-value 
Age, for increment 
of 1 year 
1.12  
(1.05-1.20) 
0.001 1.09  
(1.01-1.19) 
0.03 1.10  
(1.06-1.15) 
<0.001 
Alcohol 
consumption ≥91 
g/week, highest 
fourth vs. others 
    1.64  
(1.13-2.39) 
0.009 
Body mass index, 
for increment of 3.5 
kg/m2 
1.48  
(1.18-1.87) 
0.001 1.44  
(1.10-1.90) 
0.009 1.20  
(1.01-1.43) 
0.04 
Cardiovascular 
disease history, yes 
vs. no 
2.31  
(1.24-4.28) 
0.008 2.19  
(1.03-4.68) 
0.04   
Cigarette smoking, 
for increment of 299 
cigarette-years 
1.44  
(1.22-1.70) 
<0.001 1.43  
(1.15-1.76) 
0.001 1.45  
(1.30-1.61) 
<0.001 
Myocardial ischemia 
during exercise test, 
yes vs. no 
3.13  
(1.75-5.59) 
<0.001 4.29  
(2.17-8.49) 
<0.001   
Serum HDL 
cholesterol, for 
decrement of 0.29 
mmol/l 
    1.22  
(1.01-1.47) 
0.04 
Systolic blood 
pressure at rest, for 
increment of 15 
mmHg 
    1.32 
 (1.14-1.53) 
<0.001 
Workload at heart 
rate of 100 
beats/min, for 
decrement of 31 
Watts 
1.72  
(1.27-2.38) 
0.001 1.89  
(1.28-2.78) 
0.001   
 
* From Cox regression models adjusted for age, examination year, alcohol consumption, body mass 
index, cigarette smoking, cardiovascular disease history, diabetes, myocardial ischemia during 
exercise test, serum low-density and high-density lipoprotein cholesterol, systolic and diastolic blood 
pressure at rest, and exercise test protocol. The relative risks are shown only for variables included in 
the final model after a backward stepwise selection. Except for age, alcohol consumption, 
cardiovascular disease history, diabetes, and myocardial ischemia during exercise test, the relative 
risks were calculated for a change of 1 standard deviation, as shown. CI, confidence interval; HDL, 
high-density lipoprotein. 
 
 
 
 
  62
 
1614121086420
0,15
0,10
0,05
00,00
C
um
ul
at
iv
e
in
ci
de
nc
e
of
 C
V
D
 d
ea
th
s
Years of follow-up
WL100 <50 W
WL100 ≥50 W
 
C
um
ul
at
iv
e
in
ci
de
nc
e
of
 C
H
D
 d
ea
th
s
Years of follow-up
1614121086420
0,10
0,05
00,00
WL100 ≥50 W
WL100 <50 W
 
Figure 4. Kaplan-Meier curves for cumulative incidence of CVD (upper graph) and CHD (lower graph) 
deaths in men men with WL100 <50 W and men with WL100 ≥50 W. 
 
5.1.1 Workload at heart rate of 100 beats/min, other heart rate-derived and exercise 
test variables, and mortality 
In a Cox model that included age, examination year, exercise test protocol, conventional 
risk factors chosen by stepwise selection, and the HR-derived and exercise test variables in 
turns, a 28 unit (1 SD) increment in chronotropic index at HR of 100 beats/min was 
associated with a 43% (95% CI 9%-88%, p=0.01) increase in CVD mortality and a 65% 
(19%-128%, p=0.003) increase in CHD mortality, an increment of 10 beats/min (1 SD) in 
resting HR was associated with a 39% (0%-92%, p=0.05) increase in CHD mortality, a 
decrement of 7.3 ml/kg/min (1 SD) in VO2max, that equals to about 2.1 metabolic 
equivalents, was associated with a 59% (95% CI 0%-150%, p=0.05) increase in CHD 
mortality, and a decrement of 46 W (1 SD) in maximal workload was associated with a 
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52% (0%-133%, p=0.05) increase in CHD mortality. WL100 improved the predictive value 
of all models, except the model predicting CVD mortality that included chronotropic index 
at HR of 100 beats/min. Whereas the predictive value of WL100 was consistent across the 
models shown in Table 5, no other HR-derived or exercise test variable remained a 
significant predictor of death in models that included WL100.  
 
5.1.2 Workload at heart rate of 100 beats/min and mortality: further adjustments 
When a low blood haemoglobin concentration (<135 g/l) was entered into the model the 
predictive value of WL100 for CVD and CHD death remained unchanged. The mean (SD) 
WL100 was 65 (29) W and 62 (32) W in men tested according to early and later testing 
protocol, respectively (p=0.30 for difference after adjustment for age). To address the 
effect of a testing protocol, the survival analysis was conducted separately for subjects 
performing the two different protocols. In 528 men tested according early protocol, WL100 
as a continuous variable remained in the final model after stepwise selection for both CVD 
(p=0.04) and CHD (p=0.02) mortality. Among the 786 men tested according to later 
protocol, WL100 also remained in the final model for both CVD (p=0.02) and CHD 
mortality (p=0.03). Finally, 400 men who had cancer (n=21), CVD (n=190), chronic 
obstructive pulmonary disease, bronchial asthma or pulmonary tuberculosis (n=149), or 
dizziness, dyspnea, chest pain, arrhythmia, ischemic ECG changes or change in BP as a 
cause of discontinuation of a test (n=109) were excluded. After stepwise selection CVD 
mortality increased by 59% (95% CI 4%-144%, p=0.03), and CHD mortality by 100% 
(25%-223%, p=0.004) with a 30 W decrement in WL100.  
 
5.2 WORKLOAD AT HEART RATE OF 100 BEATS/MIN DURING EXERCISE 
TEST AND MORTALITY IN MEN WITH KNOWN OR SUSPECTED 
CORONARY HEART DISEASE 
 
At the beginning of the follow-up, the median age of the subjects was 54 years (range 42-
61 years). A total of 125 men (34.2%) used HR-lowering medication, including beta-
blockers (118 men, 32.3%), digoxin (24 men, 6.6%), and clonidin (1 man, 0.3%). Of 118 
beta-blocker users, 95 men (80.5%) used β1-selective agents and 23 men (19.5%) used 
non-selective agents. The use of HR-lowering medication was not suspended because of 
exercise test. The mean (SD) WL100 was 69 W (34 W). Baseline characteristics according 
to halves of WL100 are shown in Table 6. Resting HR explained 38%, chronotropic index at   
     
Table 5. Workload at Heart Rate of 100 Beats/min and Cardiovascular Disease and Coronary Heart Disease Mortality After Adjustment for 
Heart Rate and Exercise Test Variables* 
 Cardiovascular disease mortality Coronary heart disease mortality 
Heart rate –derived or exercise test 
variable entered into adjusted model 
before WL100  
P value for improvement 
of the model after entering 
WL100 into the model 
Relative risk (95% CI) of 
CVD death per each 
increment of 1 SD in 
WL100 
P value for improvement 
of the model after entering 
WL100 into the model 
Relative risk (95% CI) of 
CHD death per each 
increment of 1 SD in 
WL100 
Resting heart rate 0.002 1.89 (1.25-2.86) 0.005 2.04 (1.23-3.45) 
Maximal heart rate  0.004 1.64 (1.16-2.33) <0.001 2.13 (1.41-3.23) 
Maximal oxygen uptake  0.006 1.56 (1.12-2.17) 0.002 1.79 (1.22-2.63) 
Chronotropic index at heart rate of 100 bpm 0.09 1.39 (0.95-2.00) 0.03 1.67 (1.05-2.63) 
HR reserve 0.008 1.54 (1.11-2.17) 0.001 1.89 (1.25-2.78) 
Maximal workload  0.009 1.56 (1.11-2.22) 0.004 1.79 (1.19-2.70) 
 
* CI, confidence interval; CVD, cardiovascular disease; CHD, coronary heart disease; WL100, workload at heart rate of 100 beats/min; bpm, beats/min. Adjusted for 
risk factors chosen after stepwise selection before the variables in the left column and workload at heart rate of 100 beats/min were entered into the model in turns. 
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HR of 100 beats/min 18%, maximal HR 11%, and VO2max 5%, and all these variables 
together 72% of the variance in WL100 in multiple stepwise regression analysis. 
 
Men with a low WL100 were 2 times more likely to die during follow-up than men with a 
high WL100 (Table 6). The risk of death increased by 56% (95% CI 20%-100%, p=0.001) 
with 1 SD (34 W) decrement in WL100 when adjusted for age, examination year, testing 
protocol, and use of HR- lowering medication. After further adjustment for conventional 
risk factors, the risk of death increased by 72% (95% CI 32%-122%, p<0.001) with 1 SD 
(34 W) decrement in WL100 (Table 7). Finally, entering the whole set of covariates did not 
affect on WL100 as an independent predictor of death (p<0.001). 
 
WL100 was also predictive of CVD and CHD death. After adjustment for conventional risk 
factors, the risk of CVD death increased by 59% (95% CI 11%-127%, p=0.01), and the 
risk of CHD death increased by 56% (4%-138%, p=0.03) with 1 SD (34 W) decrement in 
WL100. In men who had at least 2 years of event-free follow-up from baseline, the risk of 
death increased by 69% (95% CI 28%-127%, p<0.001) with 1 SD (34 W) decrement in 
WL100 after adjustment for other risk factors. 
 
Table 6. Baseline Characteristics in 374 Men with Known or Suspected Coronary Heart 
Disease at Baseline 
Characteristics Mean (SD), median (range) or proportion p-value for 
difference 
between 
groups§ 
 All men 
(n=365) 
WL100 below median 
value 69 Watts 
(n=182)#  
WL100 above median 
value 69 Watts 
(n=183)# 
 
Number of deaths 75 48 27 0.004 
Age (years) 54 (42-61) 54 (42-61) 55 (42-61) 0.65 
Body mass index (kg/m2) 27.3 (3.7) 27.4 (4.1) 27.2 (3.3) 0.63 
Cigarette smoking 
(cigarette-years)† 
195 (359) 226 (409) 165 (300) 0.11 
Alcohol consumption 
(g/week) 
81 (170) 94 (216) 69 (105) 0.18 
Cardiac insufficiency (%) 14.0 11.5 16.4 0.22 
Diabetes (%)‡ 7.1 8.2 6.0 0.40 
Use of heart rate-lowering 
medication (%) 
34.2 19.8 48.6 <0.001 
History of myocardial 
infarction (%) 
24.7 18.7 30.6 0.01 
Serum HDL cholesterol 
(mmol/l) 
1.26 (0.33) 1.28 (0.32) 1.25 (0.33) 0.34 
Serum LDL cholesterol 
(mmol/l) 
4.05 (1.05) 4.10 (1.07) 4.01 (1.03) 0.42 
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Table 6. Continued     
 All men 
(n=365) 
WL100 below median 
value 69 Watts 
(n=182)#  
WL100 above median 
value 69 Watts 
(n=183)# 
 
Diastolic blood pressure at 
rest (mmHg) 
87 (10) 90 (10) 85 (10) <0.001 
Systolic blood pressure at 
rest (mmHg) 
133 (18) 136 (17) 130 (17) 0.001 
Maximal oxygen uptake 
(ml/kg/min) 
26.8 (7.0) 27.1 (7.5) 26.6 (6.6) 0.68 
Myocardial ischemia during 
exercise test (%)¶ 
11.5 11.0 12.0 0.78 
Resting heart rate 
(beats/min) 
67 (11) 73 (10) 61 (8) <0.001 
Chronotropic index at heart 
rate of 100 beats/min* 
1.12 (0.27) 1.25 (0.29) 0.98 (0.15) <0.001 
Maximal heart rate 
(beats/min) 
142 (22) 151 (20) 134 (21) <0.001 
Heart rate increase from rest 
to 50 Watts (beats/min) 
28 (10) 32 (10) 24 (8) <0.001 
Heart rate increase from rest 
to 33% of maximal 
workload (beats/min) 
27 (10) 30 (11) 24 (9) <0.001 
Heart rate reserve 
(beats/min)|| 
75 (22) 78 (22) 73 (22) 0.03 
Workload at heart rate of 
100 beats/min (Watts) 
69 (34) 42 (18) 97 (22) <0.001 
 
* Chronotropic index at heart rate of 100 beats/min was calculated as ((100 – resting heart rate) / 
(maximal heart rate – resting heart rate)) / (workload at heart rate of 100 beats/min / maximal 
workload) (16). 
† Cigarette-years denotes the lifelong exposure to smoking which was estimated as the product of years 
smoked and the number of cigarettes smoked daily at the time of examination (Salonen et al. 1991) . 
‡ Diabetes was defined as fasting glucose ≥6.7 mmol/l or use of medication for diabetes.  
§ Difference in age was tested with Mann-Whitney U-test. Differences in number of deaths, cardiac 
insufficiency, diabetes, history of myocardial infarction, heart rate-lowering medication, and 
myocardial ischemia during exercise test were tested with logistic-regression analysis and differences 
in rest of the variables with linear regression analysis after adjustment for age. 
|| Heart rate reserve was calculated as maximal heart rate – resting heart rate.  
¶ Myocardial ischemia during exercise test was defined as a horizontal or downsloping ST depression 
of >1.0 mm at 80 msec after the J-point or any ST depression of >1.0 mm at 80 msec after the J-point  
#          WL100, workload at heart rate of 100 beats/min. 
 
The best cut-off point for predicting mortality was 55 W, and 130 (35.6%) of all 365 men 
had WL100 <55 W. When WL100 was entered as a dichotomous variable into the backward 
stepwise Cox model including other risk factors, the strongest predictor of death was 
WL100 <55 W (RR 2.4, 95% CI 1.5-4.0, p<0.001), followed by a self-reported history of 
cardiac insufficiency (p=0.004), a history of myocardial infarction (p=0.006), diastolic 
blood pressure at rest (p=0.03), and age (p=0.04). 
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Table 7. Risk factors for death in 365 men with known or suspected coronary heart disease at 
baseline*  
Risk factor Relative risk 
(95% CI) 
p-value 
Age, for increment of 1 year 1.08 (1.01-1.15) 0.02 
Cardiac insufficiency, yes vs. no 2.42 (1.36-4.32) 0.003 
History of myocardial infarction, yes vs. no 2.21 (1.32-3.71) 0.003 
Workload at heart rate of 100 beats/min, for decrement of 34 
Watts 
1.72 (1.32-2.22) <0.001 
 
*     From Cox regression adjusted for age, examination year, alcohol consumption, body mass index, 
cigarette smoking, cardiac insufficiency, diabetes, history of myocardial infarction, myocardial 
ischemia during exercise test, serum low-density and high-density lipoprotein cholesterol, systolic and 
diastolic blood pressure at rest, testing protocol, and use of heart rate-lowering medication. The 
relative risks are shown only to the variables which were included in the final model of a backward 
stepwise selection. Except for age, cardiac insufficiency, and history of myocardial infarction, the 
relative risks were calculated for a change of 1 standard deviation, as shown. CI, confidence interval. 
 
5.2.1 Workload at heart rate of 100 beats/min, other heart rate-derived and exercise 
test variables, and mortality 
In a Cox model that included age, examination year, testing protocol, use of HR-lowering 
medication, conventional risk factors chosen by stepwise selection, and the HR-derived 
and exercise test variables in turns, the risk of death increased by 32% (95% CI 5%-66%, 
p=0.02) with 11 beats/min increment in resting HR; by 47% (95% CI 10%-100%, p=0.01) 
with 7.0 ml/kg/min decrement in VO2max; and by 35% (95% CI 3%-75%, p=0.03) with 43 
W decrement in maximal workload. Entering WL100 into these models improved the 
predictive value of the model statistically significantly in each case. The predictive value 
of WL100 remained stable in various models summarized in Table 8. Of other HR-derived 
and exercise test variables, only VO2max remained a statistically significant predictor of 
death in the models including WL100. In that model, mortality increased by 35% (95% CI 
1%-82%, p=0.05) with 7.0 ml/kg/min decrement in VO2max, while WL100 was an 
independent predictor (p=0.002) as well. 
 
5.2.2 Workload at heart rate of 100 beats/min, the use of heart rate-lowering 
medication, and mortality 
The mean (SD) WL100 was 61 W (29 W) in 240 men not using HR-lowering medication 
and 86 Watts (36 W) in 125 men using the medication (p<0.001 for difference between 
groups).  WL100 was chosen after stepwise selection to final models predicting mortality in 
both subgroups. In men not using HR-lowering medication, the strongest predictor of death 
was a history of myocardial infarction (p=0.001), followed by WL100 and age (p=0.01).  
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Table 8. Workload at heart rate of 100 beats/min and mortality after adjustment for heart 
rate -derived and exercise test variables in 365 men with known or suspected coronary heart 
disease at baseline* 
Heart rate –derived or exercise test variable 
entered into adjusted model before WL100  
Improvement of the 
model after entering 
WL100 into the 
model 
Relative risk (95% CI) of 
death per each decrement 
of 1 SD in WL100 
Resting heart rate 0.006 1.56 (1.12-2.17) 
Heart rate increase from rest to 50 Watts  0.001 1.59 (1.20-2.13) 
Heart rate increase from rest to 33% of maximal 
workload  
<0.001 1.61 (1.23-2.08) 
Maximal heart rate  <0.001 1.72 (1.32-2.27) 
Maximal oxygen consumption 0.001 1.52 (1.18-1.96) 
Chronotropic index at heart rate of 100 beats/min  0.001 1.64 (1.20-2.17) 
Heart rate reserve  <0.001 1.59 (1.23-2.04) 
Maximal workload  0.002 1.52 (1.16-2.00) 
 
* Adjusted for risk factors chosen after stepwise selection before the variables in the left column and 
workload at heart rate of 100 beats/min were entered into the model in turns. WL100, workload at 
heart rate of 100 beats/min; CI, confidence interval; SD standard deviation.   
 
The risk of death increased by 54% (95% CI 14%-108%, p=0.005) with 1 SD (29 W) 
decrement in WL100. In men using HR-lowering medication, the strongest predictor of 
death was cardiac insufficiency (p=0.004), followed by WL100 and diastolic blood pressure 
at rest (p=0.04). The risk of death increased by 72% (95% CI 14%-163%, p=0.01) with 1 
SD (36 W) decrement in WL100. There was no interaction between WL100 and the use of 
HR-lowering medication (p=0.94). No interactions of WL100 with clinical or exercise test 
variables shown in Tables 1 and 3 were found, either. 
 
5.2.3 Workload at heart rate of 100 beats/min and mortality: further adjustments 
When a low blood hemoglobin concentration (<135 g/l) was entered into the model the 
predictive value of WL100 for death remained unchanged. The mean (SD) WL100 was 69 
(31) W and 70 (36) W in men tested according to early and later testing protocol, 
respectively (p=0.36 for difference after adjustment for age and use of HR-lowering 
medication). To address the effect of a testing protocol the survival analysis was conducted 
separately for subjects performing the two different protocols. In 169 men tested according 
to early protocol WL100 as a continuous variable remained in the final model after stepwise 
selection (p=0.04).  Among the 196 men tested according to later protocol WL100 also 
remained in the final model (p=0.001). Finally, 176 men who had cancer (n=7), 
cardiomyopathy, claudication, or a history of stroke (n=53), chronic obstructive pulmonary 
disease, bronchial asthma or pulmonary tuberculosis (n=61), or dizziness, dyspnea, chest 
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pain, symptoms of cardiac insufficiency, arrhythmia, ischemic ECG changes or change in 
BP as a cause of discontinuation of a test (n=100) were excluded. After stepwise selection 
mortality increased by 89% (95% CI 28%-178%, p=0.001) with a 30 W decrement in 
WL100 among the remaining men.  
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6 DISCUSSION 
 
6.1 METHODOLOGICAL ASPECTS 
 
6.1.1 Study design 
The prevention of diseases can only be achieved when factors that predict disease 
outcomes are identified and prevented or treated (Brotman et al. 2005). Well-controlled 
experimentation is the best way to determine if a variable causally contributes to an 
outcome, but for practical and ethical reasons, it is usually impossible to hold biological 
factors constant in human research (Brotman et al. 2005). Additionally, several risk factors 
for a given outcome interact so that a particular variable may predict an outcome when 
considered univariately but in reality the association may be through other variables 
(Froelicher and Myers 2006). Therefore, multivariable statistical models called survival 
analysis are used to assess possible causal factors for an outcome, permitting estimation of 
the unique effects of a particular variable on the outcome while statistically holding other 
variables constant (Shetler et al. 2001, Brotman et al. 2005, Froelicher and Myers 2006). 
Such models help identify risk factors for an outcome, allow formulating risk stratification 
tools, and often may suggest pathophysiological mechanisms (Brotman et al. 2005). 
However, causation can never be definitively discerened from observational data sets, 
regardless of the statistical tools used, including testing for independence (Brotman et al. 
2005). The most common technique for multivariable survival analysis is the Cox 
proportional hazards model (Shetler et al. 2001, Froelicher et al. 2002, Froelicher et al. 
2003) which was used in the present study as well. Only three (Ekelund et al. 1988, 
Slattery and Jacobs 1988, Pardaens et al. 1996) of seven previous studies exploring the 
association between submaximal HR at exercise test and CVD events in asymptomatic 
subjects (Table 2) reported the result from multivariable model.     
 
The accepted way to analyze relationships between multiple risk factors and an outcome is, 
if possible, to include all relevant risk factors in the statistical model to determine the 
adjusted effect of each risk factor on the outcome (Brotman et al. 2005). If, after 
adjustment, a risk factor maintains a statistically significant association with the outcome, 
it is called an independent risk factor for the outcome (Brotman et al. 2005). However, no 
study will ever properly model all cardiovascular risk factors to assert that a particular 
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variable is truly an independent risk factor for a given CVD outcome (Brotman et al. 
2005). Any claim that a given variable is an independent risk factor for a given CVD 
outcome (except in a particular study) ignores the likelihood of residual counfounding, ie. 
that valuable predictors also associated with a variable of main interest have been 
excluded, poorly measured, or incorrectly modeled (Brotman et al. 2005). Hence, terms 
such as independent risk factor or independent predictor have meaning only in the context 
of a particular statistical model (Brotman et al. 2005). Importantly, in the current study a 
large number of established and potential risk factors were measured at baseline, and 
consequently it was possible to evaluate their impact on the association of WL100 with 
outcomes thoroughly. However, the possibility of residual confounding due to some 
unmeasured factors can not be excluded. 
 
The length of follow-up may influence the results via opposing mechanisms. The short 
follow-up may weaken the associations if only a relatively small number of outcome 
events occur during the follow-up. A limited number of outcome events inevitably weaken 
the power of a study to find out whether the given difference in outcome is statistically 
significant. On the other hand, false positive findings can be made due to small number of 
outcome events. The long follow-up may weaken the associations if the values of variables 
measured at baseline change considerably during a follow-up although the statistical power 
increases along with increasing number of outcome events (Peters et al. 1983). Because it 
is not known whether WL100 changed during the follow-up of the present study, it is 
impossible to evaluate the relative effects of aforesaid mechanisms. Nonetheless, the 
question can be addressed indirectly by recalculating the results according to a notional 
situation where the follow-up would have been only eight years instead of true 11 years. 
The recalculation shows that the prognostic value of WL100 impairs clearly with a shorter 
follow-up of eight years (data not shown). Assuming an unchanged trend, it can be 
speculated that the prognostic value of WL100 would have been even larger if the follow-up 
time had been extended over 11 years.    
 
Censoring refers to the removal of intervened subject from observation when the 
intervention occurs during follow-up because the intervention changes a natural course of a 
disease of a subject (Shetler et al. 2001, Froelicher et al. 2002, Froelicher et al. 2003). In 
observational studies for cardiac events the interventions leading to censoring are coronary 
artery by-pass surgery and percutaneous transluminal coronary angioplasty with or without 
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stenting (Shetler et al. 2001, Froelicher et al. 2002, Froelicher et al. 2003). In the current 
study, subjects who underwent coronary artery by-pass surgery or percutaneous 
transluminal coronary angioplasty during the follow-up were not censored at the time of 
intervention because we did not have a possibility to monitor those events during the long 
follow-up. However, in none of seven previous studies in asymptomatic subjects censoring 
was performed either.  
 
Collinearity means that at least one of the covariates can be predicted well from the other 
covariates in the model (Harrell 2001). In the present study, collinearity was tried to 
minimize by utilizing a backward stepwise selection method in Cox models. This method 
effectively limits a number of variables so that only one of two highly correlated covariates 
is left in the final model, provided its predictive value is high enough. However, the main 
results remained very much unchanged when all covariates were entered simultaneously 
into the model instead of stepwise selection method.  
 
6.1.2 Study population  
The strength of the current study is that subjects are a representative population-based 
sample of middle-aged men from eastern Finland, an area known for its high prevalence 
and incidence of CVD (Keys et al. 1984, Salonen 1988). Second, the participation rate was 
high and there were no losses to follow-up. The representative sample of men makes it 
possible to generalize the observed results in male populations. One limitation of the 
present study is that only men were enrolled. The extent to which age, gender, ethnic 
population, underlying diseases, and regular physical activity possibly modify the observed 
findings, deserves further studies.  
 
The baseline characteristics of the previous studies exploring the association between HR 
at exercise test and CVD events in asymptomatic subjects as well as those of the current 
study are gathered in Tables 2, 3 and 6. The age of the subjects in the present study is on 
the upper end of the range reported in previous studies. It is impossible to evaluate the 
exact CVD or CHD death rates in all previous studies, but crude estimates can be 
calculated in studies which reported CVD or CHD death as an outcome and the average or 
median length of the follow-up: the number of outcome events divided by the number of 
subjects divided by the the length of the follow-up. According to this equation, in two 
previous studies which reported CHD death as an outcome, the event rate was higher than 
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in the present study. The lower CHD mortality rate in the present study as compared with 
two previous studies might be due to a considerably longer follow-up in one study (Slattery 
and Jacobs 1988), as well as the inclusion of men with a clinical evidence of definite or 
probable CHD in another study (Hinkle et al. 1972). 
 
Because of the limited number of CVD deaths during the follow-up, men with a history of 
CVD (involving cardiac insufficiency, cardiomyopathy, arrhytmias, stroke or claudication) 
were included in the current study. This may potentially lead to selection bias which means 
that the study sample includes individuals with symptomatic or asymptomatic CVD who 
perform poorly in the exercise test and have an increased risk of future CVD events during 
follow-up (Ellenberg 1994). The potential selection bias was taken into account by 
including a history of CVD as a covariate in the survival analyses with men without CHD 
at baseline. Furthermore, in these men the main analyses were repeated after excluding 
men with CVD or other diseases or conditions potentially affecting the exercise test 
findings or the outcomes, but the results did not change considerably. Finally, the 
prevalence of CVD was not different between men with WL100 below or above the median 
value (Table 3). It is noteworthy, however, that by far the most common CVD were 
arrhythmias that are generally benign and have no prognostic value.  
 
The relationship of HR at submaximal workload with mortality and the risk of CVD events 
in patients with known or suspected CHD have not been investigated. Nonetheless, for 
descriptive purposes the present study can be compared with two recent studies (Falcone et 
al. 2005, Leeper et al. 2007) which explored HR increment from rest to submaximal 
workload as a predictor of death in men with known or suspected CHD. The sampling of 
subjects in the present study differs markedly from that of the previous two studies. The 
men in the present study were from a large population-based sample and the inclusion 
criteria involved a self-reported history of myocardial infarction or angina pectoris, or a 
regular use of antianginal medication. However, the study was not carried out in a clinical 
setting, and therefore the complete medical records of subjects were not available. By 
contrast, in studies conducted in one or several academic clinics the detailed objective 
clinical history of participants can be gathered easily. The subjects in the two clinical 
studies were either patients with angiographically documented CHD (Falcone et al. 2005), 
or consecutive patients referred for exercise testing (Leeper et al. 2007). The self-reporting 
unavoidably involves inaccuracy and a risk of misclassification (Froelicher and Myers 
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2006). However, in the present study the history of myocardial infarction or angina 
pectoris were based on a diagnosis made by a physician. Furthermore, the London School 
of Hygiene Cardiovascular Questionnaire (Rose et al. 1982) is a widely used and well 
validated tool for a standard, unbiased assessment of chest pain in epidemiological studies 
(Ashley et al. 2000b). It is possible that the subjects in the present study represent the wide 
spectrum of severity of CHD, and consequently the results can be generalized to even 
larger group of patients with known or suspected CHD than the results from studies 
involving subjects referred for exercise testing (Ellenberg 1994). Moreover, men in the 
current study can be considered as patients who according to current guidelines (Gibbons 
et al. 2002b) should be referred for exercise testing either for diagnostic purposes or for 
evaluation of prognosis and treatment options.  In this respect, the subjects of the current 
study resemble those in the study by Leeper et al (Leeper et al. 2007). The number of 
subjects was lower and the subjects were younger, but the length of follow-up was about 
twice as long in the current study as in two previous studies in patients with known or 
suspected CHD (Falcone et al. 2005, Leeper et al. 2007), respectively. The estimated crude 
outcome rates for all-cause, CVD and CHD death were very similar in all these studies. 
 
We deliberately excluded men who used HR-lowering medication in studies which 
involved men without CHD at baseline. The same trend has been observed also in previous 
studies exploring the association between submaximal HR at exercise test and CVD events 
in asymptomatic subjects because in three (Sobolski et al. 1987, Ekelund et al. 1988, 
Pardaens et al. 1996) of seven studies the users have been excluded and in only one 
(Hinkle et al. 1972) study they have been included in the study sample (Table 2). In three 
(Wilhelmsen et al. 1976, Wilhelmsen et al. 1981, Slattery and Jacobs 1988) studies the 
presence of the users of HR-lowering medication was not reported. Definitively the future 
studies are needed to clarify the prognostic value of submaximal HR among the users of 
HR-lowering medication as well. In the current thesis a low WL100 predicted, however, all-
cause deaths both in subjects who used and not used HR-lowering medication among men 
with known or suspected CHD. 
 
6.1.3 Exercise testing 
A maximal, symptom limited exercise test was performed on an electrically braked cycle 
ergometer. The advantage of cycle ergometer is that an upper body motion is usually 
reduced, that makes it easier to measure BP and to record the ECG (Wasserman et al. 
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1999, Fletcher et al. 2001, Gibbons et al. 2002a). It is argued that a major limitation to 
cycle ergometer testing is the fatigue of the quadriceps muscles in subjects who are not 
experienced cyclists which may cause them to stop before reaching a true maximal HR 
(Fletcher et al. 2001, Gibbons et al. 2002a, Froelicher and Myers 2006). Unfortunately the 
testing protocol was changed midway through the baseline data collection so that the 
increment of workloads during first minutes of a test was different between men tested 
earlier or later during the course of baseline data collection. Because WL100 characterizes 
the early rise of HR at the beginning of a test, two different protocols could affect WL100. 
However, WL100 was not different between men tested according to different protocols. 
Furthermore, the potential effect of two different protocols was taken into account by 
including testing protocol as a forced covariate in all Cox models. Finally, WL100 was 
included as a statistically significant predictor in the final Cox models after stepwise 
selection performed separately in men tested with both earlier and later protocol. These 
findings suggest that the difference in the testing protocols had no effect on the results. 
 
HR was recorded from ECG as the reciprocal of the time interval between successive R 
peaks obtained from sample interval of approximately three seconds and measured 
digitally by ECG. The difference between the measured HR and the true HR (determined 
by the last 30 seconds of each minute during exercise) is inversely related to the sampling 
interval (Atwood et al. 1989). It is possible that the measurement of HR would have been 
more accurate if a longer measurement interval had been used. Hence, the possible 
inaccuracy associated with a short sampling interval rather weakens than falsely strengtens 
the predictive value of HR variables observed in the present study.  
 
In men without CHD at baseline myocardial ischemia during exercise test was defined as 
horizontal or downsloping ST depression with 0.5 or more mm at 80 milliseconds after J 
point instead of conventionally used cut-off value of 1.0 mm. A ST depression of 0.5 mm 
was used as a cut-off value for definition, as in the early reports from the KIHD data 
(Salonen et al. 1991, Lakka et al. 1994, Salonen et al. 1995), because in univariate Cox 
model it was a stronger predictor of the outcome than 1.0 mm ST depression. In men with 
known or suspected CHD, 1.0 mm ST-depression was used as a cut-off value, however, 
because the prevalence of ischemic change in exercise ECG would have been quite large 
(84%) if 0.5 mm ST depression had been used. More importantly, the main results were 
practically unchanged although ST-depression of 0.5 mm was replaced by 1.0 mm as a cut-
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off value in men without CHD at baseline, and vice versa in men with known or suspected 
CHD.  
 
The strength of the present study is that cardiorespiratory fitness was measured objectively 
by direct expiratory gas analysis instead of using predicted values. The use of direct 
expiratory gas analysis can greatly supplement exercise testing by adding precision and 
reproducibility as well as increasing the yield of information concerning cardiopulmonary 
function (Myers 1996, Wasserman et al. 1999, Myers and Madhavan 2001). Importantly, a 
submaximal effort at peak exercise can be objectively evaluated based on respiratory 
exchange ratio as well (Myers 1996, Wasserman et al. 1999, Gibbons et al. 2002a). VO2max 
is considered the best index of aerobic capacity and maximal cardiorespiratory function 
(Myers 1996, Fletcher et al. 2001, Gibbons et al. 2002a). As VO2 is determined primarily 
by cardiac output in the absence of pulmonary or skeletal limitations, this allows for the 
use of VO2max as an estimate of cardiovascular function during physical stress (Rowell 
1993, Wasserman et al. 1999). Predicting VO2 from cycle ergometer workload is a 
common clinical practice, but such predictions can be very misleading (Myers 1996, 
Wasserman et al. 1999, Myers and Madhavan 2001). In the current study, exercise testing 
with both conventional indirect definition of exercise capacity and respiratory gas analysis 
was used which is unique in a large population study. The accurate measurement of VO2max 
assured the reliable and unbiased estimation of the predictive value of cardiorespiratory 
fitness. The predictive value of other exercise test variables independent of 
cardiorespiratory fitness could be assessed more reliably as well.  
 
6.1.4 Collection and classification of outcome events   
During the follow-up of the current study it was possible to to assess both cause-spesific 
and overall mortality as hard end points. The present study is based on reliable data on 
outcome events because deaths were ascertained from the Finnish National Death Registry 
using personal identification codes. The coding of cause of death in the Finnish National 
Death Registry has been validated (Lahti and Penttila 2001). Additionally, the validity of 
diagnoses of CHD deaths in the Finnish National Death Registry has been addressed and 
its use in endpoint assessment in epidemiological studies has been justified (Rapola et al. 
1997, Mahonen et al. 1999).  
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Four (Wilhelmsen et al. 1976, Wilhelmsen et al. 1981, Sobolski et al. 1987, Pardaens et al. 
1996) of seven previous studies exploring the association between submaximal HR at 
exercise test and CVD events in asymptomatic subjects (Table 2) used composite end 
points (fatal or nonfatal CVD event) as an outcome. The several problems accompanying 
composite end point has been discussed thoroughly (Freemantle et al. 2003, Lauer and 
Topol 2003). One of the main problems is that variables predicting nonfatal CVD events 
can be different than those predicting CVD death, creating a situation where one 
variables’s contrasting effects with respect to two end points can cancel each other out 
(Shetler et al. 2001, Froelicher et al. 2002, Froelicher et al. 2003). Among fatal end points, 
all-cause mortality is suggested to be objective, unbiased, and clinically relevant (Gottlieb 
1997, Lauer et al. 1999). On the other hand, CVD mortality is proposed to be more 
appropriate for evaluating the prognostic value of exercise test variables because exercise 
test is used to assess the response of a cardiovascular system to a standardized stress 
(Froelicher and Myers 2006). In the present study, to avoid inherent problems associated 
with composite end points, death from CVD or CHD, as well as total mortality was used as 
main outcome.  
 
6.2. RESULTS 
 
The results of the present study support the main hypothesis that a bimodal relationship 
exists between HR and prognosis as presented in Figure 2. The actual HR-workload-curve 
shown in Figure 3 resembles the hypothetical curve in Figure 2 although the distance 
between curves is exaggerated in the latter curve. 
 
The workload achieved at HR of 100 beats/min during exercise test (WL100) reflects 
physiological responses to early stages of the exercise test and is determined by resting 
HR, maximal HR, cardiorespiratory fitness, and steepness of the early HR rise as related to 
overall HR increase (Figure 5). Because both a high resting HR (Keys et al. 1966, Hesse et 
al. 2005, Jouven et al. 2005) and a low cardiorespiratory fitness (Morris et al. 1991, Mark 
and Lauer 2003, Lauer et al. 2005) are known risk factors for death and CVD events both 
in asymptomatic persons and in patients with known or suspected CHD, we hypothesized 
that a low WL100 is an independent predictor for adverse outcomes. 
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The principal findings of the study is that a low WL100 was associated with an increased 
CVD and CHD mortality in men who did not have a prior CHD at baseline, and with an 
increased mortality in men with a known a suspected CHD at baseline. The association 
was independent of other HR-derived or other exercise test variables, and the magnitude of 
the association was comparable with that of conventional risk factors. In two previous 
studies with a similar finding (Ekelund et al. 1988, Slattery and Jacobs 1988), a high HR at 
a fixed submaximal workload, which equals a low workload at a fixed HR, has been 
considered as a surrogate measure of a low cardiorespiratory fitness, and the prognostic 
value of a high submaximal HR has been explained by this assumption (corresponding to 
graph c in Figure 5). Moreover, in those studies the actual maximal cardiorespiratory 
fitness was not measured and thereby could not be included as a covariate in the analysis. 
In the present study, a low WL100 was a strong predictor of premature CVD, CHD and all-
cause death even after adjustment for directly measured VO2max which means that a low 
cardiorespiratory fitness did not explain the association of a low WL100 with outcomes.  
 
rest maximal exercise
HR
100
a)
rest maximal exercise
HR
100
b)
rest maximal exercise
HR
100
c)
rest maximal exercise
HR
100
d)
 
Figure 6. The graph illustrating how a high resting heart rate (a), a high maximal heart rate (b), a low 
cardiorespiratory fitness (c), and a disproportionately increasing heart rate at light workloads (d) each can 
have a lowering effect on workload achieved at heart rate of 100 beats/min as shown by broken lines.    
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This interesting finding suggests that an exaggerated HR response at low workload 
indicates an increased risk by itself instead of being only a surrogate marker of a low 
cardiorespiratory fitness.  
 
Resting HR was the most significant individual determinant of WL100 and an independent 
predictor of outcomes as well. A high resting HR has been considered as a surrogate 
measure of a reduced parasympathetic tone (Palatini and Julius 1997b) which is a known 
risk factor for CVD events in asymptomatic subjects (Tsuji et al. 1996, Huikuri et al. 1998, 
Makikallio et al. 2001) and cardiac patients (Schwartz et al. 1992, Schwartz 1998, Freeman 
et al. 2006). Although the mechanism of the association is unknown, it has been suggested 
that a reduced parasympathetic tone makes an individual vulnerable to fatal ventricular 
arrhythmias in circumstances that may induce them, such as myocardial ischemia 
(Schwartz et al. 1992, Schwartz 1998). It is possible that a high resting HR in men with a 
low WL100 reflects an impaired vagal control of the heart but it is noteworthy, however, 
that a resting HR did not weaken the prognostic value of WL100 when entered in the same 
Cox model. Unfortunately directly measured information on autonomic nervous system 
status (e.g. heart rate variability) is not available is the present study.  
 
A continuosly elevated resting HR and exaggerated HR responses to daily stressful 
situations may burden cardiovascular system and enhance progression of athesclerosis 
(Perski et al. 1992, Huikuri et al. 1999) via several mechanisms (Palatini 1999a, Palatini 
and Julius 2004, Palatini et al. 2006). An elevated HR may be a sign of chronic 
sympathetic nervous system overactivity which may induce numerous unfavourable 
changes from the viewpoint of cardiovascular health, as discussed previously. Because the 
cardiac work is a product of HR, stroke volume and BP, a consistently elevated HR will 
impose greater cardiac work (Julius et al. 1998). The direct atherosclerotic effect of a high 
HR on the arterial wall can be explained by the intensification of the pulsatile nature of the 
blood flow and the associated changes in the shear stress (Gordon et al. 1981, Palatini 
1999a, Palatini et al. 2006). High HR is associated with a longer time spent in systole, 
during which changes in the rate of blood flow and departures from laminar flow are 
largest (Palatini and Julius 1997a, Palatini 1999a). The increase in arterial wall stress 
caused by a high HR can also be the result of the higher mean BP in individuals with 
tachycardia (Palatini 1994) which is due to the progressive shortening of the diastolic 
phase of the cardiac cycle (Palatini and Julius 1999, Palatini and Julius 2004). The 
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increased arterial wall stress may perturb intercellular junctions, increase permeability of 
the endothelial cells and favour the ingress of atherogenic particles leading to 
atherosclerotic plaques (Gordon et al. 1981, Bassiouny et al. 1994, Palatini 1999a). In rats, 
carotid artery compliance and distensibility have been shown to be markedly impaired by 
the progressive increase in HR caused by pacing (Mangoni et al. 1996). This might be due 
to the fact it takes a certain time for the arterial wall to distend fully in response to BP 
variations (Palatini and Julius 2004). On the other hand, pharmacologic HR reduction 
induced a significant decrease in thoracic aorta wall thickness in rats (Albaladejo et al. 
2003). In CHD patients, hemodynamic forces resulting from increased HR may favour 
vulnerable coronary plaque disruption (Heidland and Strauer 2001). In patients with 
restricted coronary blood flow a high HR can further increase cardiac ischemia and 
precipitate the occurrence of arrhythmias as well as impair left ventricular performance by 
increasing myocardial oxygen demand, facilitating desynchronization of ventricular 
myocardial cells and worsening coronary perfusion (Palatini 1999b, Palatini and Julius 
2004).     
 
WL100 was recorded directly at HR 100 beats/min or interpolated linearly as a function of 
HR by using resting HR and the nearest HR value above 100 beats/min. The advantage of 
this method for defining WL100 is that the lowest HR values at the early phase of the 
exercise test are not required to be below 100 beats/min. An exaggerated HR rise above the 
level of 100 beats/min at the first workload is an actual phenomenon in individuals with a 
limited exercise capacity, particularly if the first workload is not adjusted for the reduced 
performance. Resting HR, when measured before the exercise test, is higher than the true 
resting HR because of nervousness, excitement and apprehension related to testing 
environment (Palatini and Julius 1997b). Because the data of the true resting HR measured 
at less stressful conditions was not available in the present study, it is impossible to 
evaluate to what extent interindividual differences in pre-test excitement affects resting HR 
values measured before test and consequently on WL100. It is possible that a pronounced 
anticipatory HR response to test includes not only a high resting HR before the test but also 
an exaggerated HR response at the first workloads (Lange Andersen et al. 1971, Wilkoff 
and Miller 1992, Åstrand et al. 2003), indicated by a low WL100. In previous reports from 
the KIHD Study, an exaggerated anticipatory BP response to exercise test has been linked 
to an increased left ventricular mass assessed by echocardiography (Kamarck et al. 2000), 
and a heightened BP response during mental stress has been linked to enhanced carotid 
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atherosclerosis (Kamarck et al. 1997, Jennings et al. 2004). Furthermore, a trend was 
observed between an exaggerated HR response during mental stress and enhanced carotid 
atherosclerosis in 4-year follow-up (Kamarck et al. 1997) but no association was observed 
to a progression of atherosclerosis from fourth to eleventh follow-up year (Jennings et al. 
2004). Thus, a low WL100 may represent a trait characterized by an exaggerated 
cardiovascular responsiveness to stressful situations (corresponding to graph d in Figure 5). 
A high chronotropic index at HR of 100 beats/min, reflecting a disproportionately steep 
HR rise at the early phase of a test, was an independent predictor of CVD and CHD death 
in men without CHD at baseline. This observation may further suggest that a trait 
characterized by an exaggerated cardiovascular responsiveness to stressful situations can to 
some extent explain the association of a low WL100 with an increased risk of outcomes in 
the current study.  
 
To recapitulate, we suggest that a low WL100 concurrently reflects a high resting HR, an 
exaggerated HR increase at the beginning of an exercise test, and a low cardiorespiratory 
performance. While these variables separately had only a limited predictive value in the 
present study, the combined variable WL100 provided valuable prognostic information 
beyond these variables. 
 
We intentionally used the workload achieved at a fixed submaximal HR instead of using 
HR at a fixed submaximal workload. This approach has a solid physiological basis, as 
explained, and it enables the testing of subjects at approximately the same relative intensity 
independent of age, gender, size of body or fitness level unlike when a fixed workload is 
used. However, the careful inspection of Figure 3 suggest that the maximal predictive 
value might be found if a slightly lower HR value than 100 beats/min was used to quantify 
a submaximal HR response. Among asymptomatic subjects the association between a high 
HR at submaximal work and an increased risk of CVD death has been observed in studies 
which have used treadmill as a testing mode (Ekelund et al. 1988, Slattery and Jacobs 
1988) and not in studies using cycle ergometer (Wilhelmsen et al. 1976, Wilhelmsen et al. 
1981, Sobolski et al. 1987, Pardaens et al. 1996) whereas in the patients with known or 
suspected CHD the findings have been just opposite (Falcone et al. 2005, Leeper et al. 
2007). Therefore it is unclear whether the testing mode affects the prognostic value of a 
high HR at submaximal work or that of WL100 and further studies are needed to address the 
issue. 
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Submaximal exercise tests have some benefits as compared with maximal tests. A low 
level of exercise enables testing of individuals with a limited exercise capacity, and 
cardiovascular risks associated with a high-intensity exertion can be largely avoided 
(Åstrand et al. 2003, Froelicher and Myers 2006). This is an important aspect in subjects 
who have any contraindication for maximal test. If necessary, the exercise test can also be 
repeated frequently because of a short recovery period needed. 
 
6.2.1 Workload achieved at heart rate of 100 beats/min during an exercise test and 
cardiovascular disease mortality in men without coronary heart disease at baseline 
The results of the present study are in accordance with two previous population-based 
studies (Ekelund et al. 1988, Slattery and Jacobs 1988) which reported that a high HR at a 
fixed submaximal workload predicts CVD and CHD deaths. As explained, 
cardiorespiratory fitness did not explain the association of a low WL100 with outcomes. 
Furthermore, the level of exercise used to explore the association of a submaximal HR and 
workload with outcomes was lower in the present study compared with two previous 
studies (Ekelund et al. 1988, Slattery and Jacobs 1988). While the minimum HR required 
for a risk assessment was 116 (Slattery and Jacobs 1988) and 133 beats/min (Ekelund et al. 
1988) in two previous studies, the mean HR to enable the risk assessment (ie. a first HR 
value above 100 beats/min) was only 104 beats/min in the present study. 
 
Interestingly, three of the four studies (Hinkle et al. 1972, Ekelund et al. 1988, Slattery and 
Jacobs 1988), including the present study, investigating CVD and CHD death as an 
outcome have found a submaximal HR variable to be a statistically significant predictor. 
Conversely, all four (Wilhelmsen et al. 1976, Wilhelmsen et al. 1981, Sobolski et al. 1987, 
Pardaens et al. 1996) previous studies exploring a composite end point, including fatal and 
nonfatal CVD events, as an outcome have not found a submaximal HR variable to be a 
statistically significant predictor. It has been suggested that variables predicting nonfatal 
CVD events can be different than those predicting death, creating a situation where one 
variables’s contrasting effects with respect to two end points can cancel each other out 
(Shetler et al. 2001, Froelicher et al. 2002, Froelicher et al. 2003). Because of a limited 
number of studies it is precipitated to state that a submaximal HR is a variable predicting 
fatal CVD events more potently than nonfatal CVD events. However, in the current study a 
low WL100 was not associated with an increased risk of AMI or nonfatal AMI, but it was an 
independent predictor of fatal AMI (15% of all AMIs). 
  83
 
One previous study (Sobolski et al. 1987) did not find the association between a low 
workload attained at HR of 150 beats/min and an increased risk of CHD event but the 
association was observed when the workload attained was expressed as divided by body 
weight. It is possible that the association was not observed because at the HR of 150 
beats/min the difference in workload between groups with adverse and good prognosis had 
already narrowed considerably although the difference might have been observed at lower 
HR levels. According to Figure 3 this could have been the case in the present study as well. 
We did not divide WL100 by body weight although there is theroretical basis for it (Åstrand 
et al. 2003). Furthermore, because a high BMI was a risk factor for death in in men without 
CHD at baseline, it is possible that a prognostic value of WL100 would have even improved 
if had been expressed as indexed for body weight.  
 
A low stroke volume may be a common denominator for a high resting HR, an exaggerated 
HR increase at the beginning of an exercise test, and a low cardiorespiratory performance 
(Rowell 1993, Åstrand et al. 2003). We could not, however, directly assess stroke volume 
in the present study and thereby its role in the association between WL100 and mortality can 
not be considered any further. The exclusion of subjects who had an outcome event within 
two years after baseline and those whose test was terminated because of symptoms or 
findings potentially due to a latent CVD did not weaken the prognostic value of WL100 
much. This suggests that a latent CVD most probably does not explain the increased risk 
associated with a low WL100. 
 
6.2.2 Workload achieved at heart rate of 100 beats/min during an exercise test and 
mortality in men with known or suspected coronary heart disease at baseline 
The results of the present study basically agree with the findings of a recent study in which 
a large HR increase from rest to the workload of 25 W at the onset of an exercise test was a 
strong predictor of adverse cardiac events and cardiac deaths in patients with CHD verified 
by angiography (Falcone et al. 2005). In the present study, HR increase from rest to the 
workload of 50 W was associated with a nonsignificant trend (p=0.11) toward increased 
risk of death after stepwise selection (data not shown). Because of the testing protocol, the 
workload of 50 W was used instead of 25 W that hampers the comparison of the results of 
these two studies. Although WL100 was not measured in the study by Falcone and 
coworkers (Falcone et al. 2005), the closer inspection indicates that men with an 
exaggerated HR response obviously had a low WL100. The researchers suggested that a 
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rapid HR increase was caused by a rapid vagal withdrawal reflecting an autonomic 
imbalance. Exercise capacity was lower in men with an exaggerated HR response but 
unfortunately an exercise capacity was not included in the Cox model as a covariate 
leaving open the possibility that an exaggerated HR response was caused by a low 
cardiorespiratory fitness.  
 
The results of the present study also agree with the findings of two previous studies in dogs 
(Billman et al. 1985, Billman and Hoskins 1989). The rise of HR at the early phase of an 
exercise stress was steeper in dogs with a healed myocardial infarction that were 
susceptible to ventricular fibrillation after experimentally induced coronary occlusion as 
compared with dogs that were resistant to ventricular fibrillation. The susceptibility to 
ventricular fibrillation was associated with a greater degree of left ventricular dysfunction 
(Billman et al. 1985) which thus probably explains a higher HR at submaximal workloads 
as well.   
 
On the contrary, in another recent study a HR increase from rest to 2 METs workload in 
treadmill was not associated with an increased risk of CVD death in patients referred for 
exercise testing (Leeper et al. 2007). Again, WL100 was not measured in the study by 
Leeper et al (Leeper et al. 2007) but the closer inspection shows that WL100 most obviously 
was not different between subjects who died of CVD during the follow-up and survivors. 
One disparity between the present study and the study by Leeper et al (Leeper et al. 2007) 
is that the latter used an individualized ramp treadmill protocol in which workload 
increments are tailored according to an estimated work capacity of a patient (Myers et al. 
1991). It has been discussed that a prognostic value of an exaggerated BP response to 
submaximal exercise is directly related to the strain of the first workload(s) as related to a 
total exercise capacity of a subject (Mundal et al. 1994). If a similar relationship exists for 
HR response too, then a discrepancy between the findings in the present study and in the 
study by Leeper et al (Leeper et al. 2007) could be to some extent attributed to different 
testing protocols used in these studies.  
 
A low WL100 could result from left ventricular dysfunction in subjects with a more severe 
CHD (Weber et al. 1982, Wasserman 1997, Myers and Madhavan 2001). Although this 
possibility can not be ruled out in the current study, an argument against this notion is that 
a low WL100 was not associated with a more prevalent history of myocardial infarction or 
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self-reported cardiac insufficiency either in men using HR-lowering medication or in 
nonusers (data not shown). More specifically, a low WL100 could originate from 
myocardial ischemia beginning already at early exercise when HR is below 100 beats/min 
(Hultgren et al. 1986, Wasserman 1997, Myers and Madhavan 2001). An early appearance 
of myocardial ischemia has been shown to associate with an adverse prognosis (McNeer et 
al. 1978, Weiner et al. 1980) and an angiographically more severe CHD (Weiner et al. 
1980). Because the data on ST-segment depression at workloads below HR of 100 
beats/min is not available, the role of an early ischemia as a link between a low WL100 and 
an increased risk of death in the present study can not be excluded either.  
 
6.3 CLINICAL IMPLICATIONS  
 
The recent consensus statements from the American Heart Association and the American 
College of Cardiology (Gibbons et al. 2002a) as well as from the US Preventive Services 
Task Force (Fowler-Brown et al. 2004) have led to recommendation against the use of 
exercise testing as a screening tool for detecting a latent CHD in asymptomatic persons. 
These recommendations have been largely based on an extensive body of literature 
documenting the limitations of the ST-segment for diagnosing CHD in asymptomatic 
subjects (Lauer et al. 2005). Still, reports on evaluation of the exercise test as a prognostic 
rather than a diagnostic test suggest that the prognostic value of the screening exercise test 
may have been underestimated (Ashley et al. 2000a, Lauer 2001b, Lauer et al. 2005). A 
latest version of the textbook written by major authorities in the field (Froelicher and 
Myers 2006) states, indeed, that exercise testing should be used for screening healthy, 
asymptomatic individuals along with risk factor assessment (Froelicher 2005). In this 
context assessment of exercise test result includes not only ST-segment diagnostics but 
other exercise test variables shown to have a prognostic value as well (Froelicher and 
Myers 2006). Nonetheless, no consensus exists whether this further risk stratification 
should be targeted to persons at an intermediate or high risk of events based on office tools 
such as the Framingham Risk Score or European Systematic Coronary Risk Evaluation 
(SCORE). Some authors have suggested that the current risk assessments based on 
conventional risk factors are especially ineffective among persons at an intermediate risk 
of events and these individuals may benefit on further risk stratification (Greenland et al. 
2001, Kullo and Malik 2007). Recent prospective studies in asymptomatic persons have 
shown, however, that an additional prognostic value from exercise testing above 
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conventional risk factors seems to be the largest in persons at a high risk of events (Aktas 
et al. 2004, Balady et al. 2004, Erikssen et al. 2004). Whatever the target group, the 
primary aim of enhanced risk stratification is to detect those individuals who would benefit 
most from targeted aggressive treatment of risk factors (Califf et al. 1996). The recent 
expert statement concluded that the next major priority is the design and implementation of 
large-scale randomized trials to determine whether an exercise screening strategy leads to 
an improvement in outcomes (Lauer et al. 2005). Additionally, these trials would provide 
much-needed evidence about the cost-effectiveness in execise testing in asymptomatic 
persons (Lauer et al. 2005). 
 
In patients with known or suspected CHD the value of exercise testing is more clearly 
established so that the post-exercise test risk assessment serves as a guide to a particulatr 
management strategy that is viewed as most appropriate, based on expected outcomes 
(Fletcher et al. 2001, Gibbons et al. 2002a). According to the guidelines of the American 
Heart Association and the American College of Cardiology (Gibbons et al. 2002a), patients 
with a low-risk exercise test result can be treated medically without need for referral to 
cardiac catheterization. Patients with a high-risk exercise test result should usually be 
referred for cardiac catheterization whereas patients with an intermediate-risk exercise test 
result should be referred for additional testing, either cardiac catheterization or an exercise 
imaging study depending on other clinical variables (Gibbons et al. 2002a).  
 
An obvious question with regard to the clinical use of WL100 is whether it is a modifiable 
risk factor. The existing literature shows that physical activity, or training lowers HR at a 
fixed submaximal workload (Fletcher et al. 2001), and thus increases WL100 as well. This 
has been observed both in healthy subjects (Karvonen et al. 1957, Camm and Fei 1996a, 
Moore and Palmer 1999) and in patients with CHD (Detry and Bruce 1971, Ehsani et al. 
1981, Myers et al. 1984). Weight loss in obese subjects is another physiological means to 
increase WL100 and this effect is especially pronounced in activities involving weight-
bearing, such as walking in treadmill.  
 
In the current study, several exercise test variables predicted outcomes independent of each 
other or conventional risk factors. This highlights the fact the maximal prognostic yield 
from exercise test is obtained by measuring several variables at submaximal and maximal 
workload as well as during recovery phase. The underestimation of exercise testing as a 
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prognostic tool has been based on a constricted assessment of solely ST-segment response 
to exercise. Several studies conducted during the last 15 years in healthy individuals as 
well as in clinical populations have undoubtedly shown that exercise testing can offer 
additional prognostic information above conventional risk markers. Consequently, 
multivariable equations and scores derived from clinical variables and exercise test results 
are considered as a highly recommended method to evaluate an individual risk for adverse 
CVD events in the future (Lauer 2001b, Lauer et al. 2005, Kligfield and Lauer 2006).  
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7 SUMMARY AND CONCLUSIONS 
 
1. A low workload achieved at HR of 100 beats/min during an exercise test predicts CVD 
and CHD death in middle-aged men without CHD at baseline, as well as all-cause death in 
men with known or suspected CHD at baseline. The association between workload 
achieved at HR of 100 beats/min and mortality is not explained solely by cardiorespiratory 
fitness as previously assumed. 
 
2. Several exercise test variables predict premature death independent of each other and 
conventional risk factors. This emphasizes that the maximal prognostic yield from exercise 
test is obtained by measuring several variables at submaximal and maximal workloads as 
well as during recovery phase. 
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